NewzIntel.com

Category: Health

  • MIL-OSI Economics: Verizon contributes $10K in response to devastating flooding in West Virginia

    Source: Verizon

    Headline: Verizon contributes $10K in response to devastating flooding in West Virginia

    WHEELING, W.V. – On June 15, devastating heavy rains and flash flooding severely impacted Ohio and Marion counties in West Virginia. This rare event saw up to 3 to 4 inches of rainfall in less than an hour in localized areas. Multiple fatalities and extensive damage to roads, bridges, buildings and homes have been reported. Thousands were left without power and the National Guard has been mobilized to support local emergency operations.

    In response to this disaster, Verizon is showing up for our customers and our neighbors in West Virginia by investing $10,000 in Appalachian Outreach, Inc. (AOI). AOI is a nonprofit that assists people experiencing poverty and disaster in Ohio, Marshall, and Wetzel counties. AOI is offering a variety of support for individuals and families impacted by the recent flooding including access to supplies, a charging station, and a comfortable place to rest and recharge. Additionally, AOI is collaborating with the Red Cross and the West Virginia Department of Health and Human Resources, to increase the number of community members they can reach directly.

    “When natural disasters unfold our priority is to swiftly mobilize resources and provide support where it’s needed most,” said Anthony Lewis, Region Vice President of State Public Policy and Government Affairs for Verizon. “As always, our team worked to keep our network stable so that West Virginians can continue to connect with each other during these difficult times. Our partnership with Appalachian Outreach, Inc., further enables the delivery of immediate relief and ongoing support residents deserve as they work to recover and rebuild.”

    “We are beyond grateful to Verizon for their compassion and commitment to West Virginia families,” said Heather Ray, Executive Director of Appalachian Outreach, Inc. “Their generous $10,000 donation comes at a time when so many in our community are hurting in the wake of devastating flash floods. This support allows us to meet urgent needs—like hygiene items, clothing, food, and cleaning supplies—while also standing beside families as they begin the long journey toward recovery. We simply couldn’t do this work without partners like Verizon who step up when it matters most.”

    This investment is part of Verizon’s larger commitment to responding to disasters across the country. Verizon is committed to helping communities prepare for, respond to, and recover from disasters with greater confidence.

    MIL OSI Economics –

  • MIL-OSI USA: Warner & Kaine Introduce Bill to Protect Access to Reproductive Health Care

    US Senate News:

    Source: United States Senator for Virginia Tim Kaine

    WASHINGTON, D.C.—Yesterday, on the third anniversary of the Supreme Court overturning Roe v. Wade, U.S. Senator Mark R. Warner and Senator Tim Kaine, a member of the Senate, Health, Education and Labor (HELP) Committee, joined Senators Tammy Baldwin (D-WI), Richard Blumenthal (D-CT), and Patty Murray (D-WA) in introducing the Women’s Health Protection Act, legislation to guarantee access to abortion care across the country. The bill’s introduction comes as the Trump Administration and Republicans continue to attack reproductive freedom. Virginia is the last southern state where abortion is still legal, and Virginia has seen an increase in demand for abortions after other states have passed laws restricting access.

    “In the three years since Roe v. Wade was overturned, we’ve seen the consequences unfold in real time: women denied lifesaving care, doctors forced to navigate confusing and dangerous legal gray areas, and families left to deal with the fallout. Decisions about pregnancy should be made between a woman and her doctor, not by politicians,” said Warner. “This bill would once and for all restore the constitutional right to abortion, permanently making it safe and legal nationwide.”

    “Three years ago, the Supreme Court took away Americans’ ability to access reproductive health care, and since then, we’ve seen the tragic impacts of this decision for women across the country,” said Kaine. “I’m proud to be joining my colleagues in introducing this legislation to protect access to abortion nationwide and restore Americans’ freedom to make their own health care decisions.”

    Since the Dobbs decision, 19 states have banned abortion or severely restricted women from being able to access the procedure, leaving one in three American women without access to safe, legal abortion care. Additionally, state legislatures across the country have introduced hundreds of bills to include medically unnecessary restrictions that limit access to abortion care. In his second term, President Trump has continued to attack reproductive rights, including freezing Title X funding for clinics that offer reproductive care, cutting Biden-era emergency abortion protections, and fighting to defund Planned Parenthood. Additionally, the House-passed Republican budget bill kicks 16 million people off their health insurance and defunds Planned Parenthood, threatening the closure of 200 health centers across the country and putting access to vital reproductive care for millions of families at risk.

    The Women’s Health Protection Act guarantees the right to access an abortion—and the right of an abortion provider to deliver these services—free from medically unnecessary restrictions that interfere with a patient’s individual choice or the provider-patient relationship. The bill also protects the ability to travel out of state for an abortion, which has become increasingly common in recent years.

    Following the Dobbs decision, Warner and Kaine have strongly advocated for legislation to protect Americans’ access to reproductive health care. The senators cosponsored legislation to protect the right of women to travel across state lines for abortion services and help protect medical providers from being punished for providing patients with this care. Kaine has also introduced the bipartisan Reproductive Freedom for All Act to protect abortion rights and contraception access.

    In addition to Warner, Kaine, Baldwin, Blumenthal, and Murray, the Women’s Health Protection Act is cosponsored by Leader Chuck Schumer (D-NY) and Senators Angela Alsobrooks (D-MD), Michael Bennet (D-CO), Lisa Blunt Rochester (D-DE), Cory Booker (D-NJ), Maria Cantwell (D-WA), Chris Coons (D-DE), Catherine Cortez Masto (D-NV), Tammy Duckworth (D-IL), Dick Durbin (D-IL), John Fetterman (D-PA), Ruben Gallego (D-AZ), Kirsten Gillibrand (D-NY), Maggie Hassan (D-NH), Martin Heinrich (D-NM), John Hickenlooper (D-CO), Mazie Hirono (D-HI), Mark Kelly (D-AZ), Andy Kim (D-NJ), Angus King (I-ME), Amy Klobuchar (D-MN), Ben Ray Luján (D-NM), Ed Markey (D-MA), Jeff Merkley (D-OR), Chris Murphy (D-CT), Jon Ossoff (D-GA), Alex Padilla (D-CA), Gary Peters (D-MI), Jack Reed (D-RI), Jacky Rosen (D-NV), Bernie Sanders (I-VT), Brian Schatz (D-HI), Adam Schiff (D-CA), Jeanne Shaheen (D-NH), Elissa Slotkin (D-MI), Tina Smith (D-MN), Chris Van Hollen (D-MD), Reverend Raphael Warnock (D-GA), Elizabeth Warren (D-MA), Peter Welch (D-VT), Sheldon Whitehouse (D-RI), and Ron Wyden (D-OR).

    Full text of the legislation is available here.

    MIL OSI USA News –

  • MIL-OSI USA: Senator Collins, Bipartisan Group Introduce Bill to Support America’s Nursing Workforce

    US Senate News:

    Source: United States Senator for Maine Susan Collins

    Washington, D.C. – U.S. Senators Susan Collins, Jeff Merkley (D-OR), Tammy Baldwin (D-WI), and Marsha Blackburn (R-TN) introduced the Title VIII Nursing Workforce Reauthorization Act of 2025. This bipartisan bill would reauthorize, update, and improve critical programs under Title VIII of the Public Health Service Act, a law passed in 1944 to support public health and health care professionals. The Title VIII Nursing Workforce Reauthorization Act reaffirms Congress’ commitment to addressing all aspects of nursing workforce demand, including education, practice, recruitment, and retention.

    “The State of Maine continues to face a serious shortage of nurses, particularly in rural communities where hospitals struggle to recruit and retain staff,” said Senator Collins. “This bipartisan legislation would help strengthen the nursing workforce by reauthorizing critical programs that support nursing education, expand access to clinical training, and help schools prepare more students for careers in nursing. Doing so is essential to addressing the workforce shortages facing hospitals across our country.”

    The Title VIII programs were last reauthorized as part of the Coronavirus Aid, Relief, and Economic Security (CARES) Act in March 2020. Under the CARES Act, the Title VIII programs are authorized through September 30, 2025.

    Specifically, the Title VIII Nursing Workforce Reauthorization Act of 2025 would:

    1. Reauthorize funding for the Title VIII Nursing Workforce Development Programs from Fiscal Year 2026 through Fiscal Year 2030;
    1. Make technical changes to the Advanced Nursing Education Program and makes clear that grants for traineeships can cover the costs for clinical education and preceptors;
    1. Allow nurse education, practice, quality, and retention grants to be used to cover the cost of audiovisual or other equipment, simulation and augmented reality resources, telehealth technologies, and virtual and physical laboratories, as well as to be used to increase the number of faculty and students at schools of nursing in order to address nursing workforce shortages; and
    1. Clarify that nurse education, practice, quality, and retention grants can be used to provide care for survivors of sexual assault and to partner with a health care facility that provides educational opportunities for the purpose of establishing or expanding clinical education.

    The Title VIII Nursing Workforce Reauthorization Act is endorsed by more than 50 organizations, including the American Association of Colleges (AACN) and the American Nurses Association (ANA).

    “Maintaining access to healthcare services is necessary for achieving the best care outcomes and keeping Americans healthy,” said Dr. Deborah Trautman, President and Chief Executive Officer of AACN. “We are thankful for the bipartisan support for the Title VIII Nursing Workforce Reauthorization Act of 2025, which helps ensure that our nursing workforce can continue to meet the needs of all communities, including those with limited access to nurses and other healthcare providers.”

    “Federal investment in Title VIII is essential to sustaining nursing schools, faculty, and students,” said Dr. Jean Giddens, Chair of the AACN Board of Directors. “With the introduction of the Title VIII Nursing Workforce Reauthorization Act of 2025, we applaud the commitment of Senator Merkley, Senator Collins, Senator Baldwin, and Senator Blackburn for their support of a thriving healthcare workforce that will have a lasting impact on both nurses and patients across the nation.”

    “We are deeply grateful to Senators Merkley and Collins for championing the reauthorization of the Title VIII Nursing Workforce Development Program. This legislation is more than funding — it is a lifeline for the nursing profession. Title VIII supports the education, training, and advancement of nurses across the country, ensuring we have a strong, skilled, and sustainable workforce ready to meet the challenges of today and tomorrow. At a time when our healthcare system depends so heavily on nurses, this investment is critical to the future of our profession and the health of our nation,” said Jennifer Mensik Kennedy, PhD, MBA, RN, NEA-BC, FAAN, President of the ANA.

    In addition to Senators Collins, Merkley, Baldwin, and Blackburn, the bill is cosponsored by Senators Richard Blumenthal (D-CT), Chris Coons (D-DE), Kirsten Gillibrand (D-NY), Mark Kelly (D-AZ), Lisa Murkowski (R-AK), and Adam Schiff (D-CA).

    The complete text of the bill can be read here.

    MIL OSI USA News –

  • MIL-OSI USA: Senators Collins, Shaheen Introduce Bipartisan Bill to Expand Access to Diabetes Self-Management Training and Lower Treatment Costs

    US Senate News:

    Source: United States Senator for Maine Susan Collins

    Washington, D.C. – U.S. Senators Susan Collins and Jeanne Shaheen (D-NH), co-chairs of the Senate Diabetes Caucus, reintroduced the Expanding Access to Diabetes Self-Management Training Act. This bipartisan legislation would expand Medicare coverage for diabetes self-management training (DSMT) sessions, where diabetes educators help train Medicare patients on how to manage their glucose, maintain a healthy weight, eat healthy foods, manage their insulin levels and improve general care for their diabetes. DSMT is associated with a reduction in risk for diabetes-related death and heart attack and, importantly, leads to improved self-care behavior and wellness, which greatly reduces hospital care costs.

    “Diabetes self-management training equips Americans with diabetes with the tools they need to successfully manage their disease,” said Senator Collins. “By supporting education and patient engagement, our bipartisan bill would improve health outcomes, enhance quality of life, and reduce health care costs by helping to prevent complications and hospitalizations.”

    “Diabetes is a lifelong condition that affects millions of Americans. Expanding access to diabetes self-management training will allow patients to improve their well-being and live healthier lives while being more self-sufficient in their care,” said Senator Shaheen. “Our bipartisan legislation would lower the cost of treatment for patients with diabetes and I’m proud to work across the aisle to continue supporting diabetes treatment, research and investment.”

    “The Association of Diabetes Care & Education Specialists (ADCES) applauds and thanks our champions, Senators Collins and Shaheen, for introducing legislation that would improve access to diabetes care and education for Medicare beneficiaries,” said ADCES President Veronica Brady, PhD, RN, FNP-P, BC-ADM, CDCES. “DSMT services help individuals with diabetes improve their health and reduce complications which in turn can decrease health care costs.”??

    There are 38.4 million Americans living with diabetes and one in three adults with prediabetes, a condition that is known to progress to diabetes without early intervention, according to the Centers for Disease Control and Prevention (CDC). Diabetes is the seventh leading cause of death in the United States and can lead to many other chronic diseases and conditions, such as blindness and kidney failure. As one of the most expensive chronic diseases, diabetes costs the American health care system billions of dollars each year. Overall, one in every ten health care dollars is spent on diabetes and its complications, and one in every three Medicare dollars is spent on the condition.

    As co-chairs of the U.S. Senate Diabetes Caucus, Senators Collins and Shaheen have led action in the U.S. Senate to advance priorities that will lower the costs of insulin, invest in treatment, and prioritize diabetes research. Last month, they introduced the Promoting Access to Diabetic Shoes Act, legislation that would improve care for patients with diabetes by allowing nurse practitioners (NPs) and physician associates/physician assistants (PAs)—who often act as sole primary care providers for many patients with diabetes—to prescribe therapeutic shoes.    

    MIL OSI USA News –

  • MIL-OSI USA: Angiographic Catheter Recall: Cook Removes Beacon Tip Angiographic Catheters due to Tip Separation

    Source: US Department of Health and Human Services – 3

    This recall involves removing certain devices from where they are used or sold. The FDA has identified this recall as the most serious type. This device may cause serious injury or death if you continue to use it. 
    Affected Product

    What to Do
    On May 15, 2025, Cook sent all affected customers a letter recommending the following actions:

    Examine inventory immediately to determine if you have affected product(s) and quarantine any affected product that remains unused. Immediately cease all further distribution and use of the affected products.
    This notice must be shared with appropriate personnel, including down to the user level, within your organization or with any organization where the affected devices have been transferred.

    Reason for Recall
    Cook has become aware that catheters supplied in the affected device lots may experience tip separation. This issue was identified through field complaints, with users reporting tip separation occurring both prior to and during patient contact.
    If an affected product is used, potential patient harms such as catheter fragmentation and embolization may occur. Medical consequences associated with device fragmentation or separation may include sepsis, vessel perforation, thrombosis, embolism, cardiac arrythmia, and death.
    Cook has reported three serious injuries and no deaths associated with this issue.
    Device Use
    Beacon Tip Catheters are intended for use in angiographic (blood vessel imaging) procedures by physicians trained and experienced in angiographic techniques. Standard techniques for placement of vascular access sheaths, angiographic catheters and wire guides should be employed.
    Contact Information
    Customers in the U.S. with adverse reactions, quality problems, or questions about this recall should contact Cook Medical at FieldActionsNA@CookMedical.com or 800-457-9120.
    Additional FDA Resources (listed in order of most to least recent):

    Unique Device Identifier (UDI)
    The unique device identifier (UDI) helps identify individual medical devices sold in the United States from distribution to use. The UDI allows for more accurate reporting, reviewing, and analyzing of adverse event reports so that devices can be identified more quickly, and as a result, problems potentially resolved more quickly.

    How do I report a problem?
    Health care professionals and consumers may report adverse reactions or quality problems they experienced using these devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program. 

    Content current as of:
    06/25/2025

    Regulated Product(s)

    MIL OSI USA News –

  • MIL-OSI USA: UConn Adopts New Budget with Strategic Adjustments to Address Funding Shortfalls

    Source: US State of Connecticut

    UConn has adopted a 2025-26 budget that maintains excellence in its academic, research, and health care enterprises while addressing serious fiscal challenges resulting from state funding shortfalls and steep reductions in federal research awards.

    The budget increases UConn’s enrollment to bolster revenue; draws from one-time fund balances in accounts throughout the institution; and enacts stringent deficit mitigation plans at UConn Storrs, UConn Health, and the regional campuses.

    UConn’s Board of Trustees adopted the budget at its meeting on Wednesday, June 25, and it goes into effect July 1.

    UConn faces operating budget shortfalls in the upcoming fiscal year of $72 million for the Storrs and regional campuses and $61.8 million for UConn Health, for a combined total of $134 million.

    UConn has also lost $95 million in reduced, slowed, and terminated federal research awards under new policies enacted nationwide since January, and there are no indicators that the funding will rebound in the near future.

    As FY26 progresses, the state Office of Policy and Management (OPM) also could reduce UConn’s appropriations to balance the state budget if needed. With so many revenue sources in flux, UConn expects to continually pivot to adjust to new developments.

    “We’re going to have to forecast and reforecast every month as these changes take place and as we continue to move forward. It’s going to be very fluid,” Jeffrey Geoghegan, UConn’s CFO and executive vice president for finance, told members of the Board of Trustees’ Financial Affairs Committee on Tuesday, June 24.

    That committee reviewed and endorsed the budget proposal and passed it on to the full board for a vote.

    UConn plans to mitigate about $38 million and UConn Health plans to mitigate about $62 million of the FY26 funding losses through several actions, including optimizing and reducing personnel. That will occur through a variety of approaches, including restricting most hiring and reviewing non-permanent and temporary positions as an initial step.

    The University will also review overtime and compensatory time; encourage voluntary schedule reductions where feasible and appropriate; consolidate some office functions; and restrict employee travel, events, and other activities.

    Wherever possible, the University will work to grow its revenue streams as well. Units have been directed to fully utilize unspent balances they hold from UConn Foundation funds. Also, the University will work to identify potential opportunities for new revenue, including continuing to grow patient care revenue at UConn Health.

    “UConn Health is committed to making the difficult decisions necessary to mitigate the reduction in funding, while at the same time continuing its position as one of the highest quality, best patient experience, and fastest growing health systems in Connecticut,” says Dr. Andrew Agwunobi, UConn Health’s CEO and executive vice president of health affairs.

    The overall FY26 operating budget totals $3.6 billion, split roughly equally between UConn Health and the UConn Storrs/regional campuses operations.

    The state’s annual block grant to the University comprised one-quarter of the University’s revenue as recently as FY19 but has been steadily decreasing. In the coming year, that number has fallen to 12% (15% at UConn and 8% at UConn Health). The state allocation covers 23% of UConn’s personnel costs; the rest is borne by the University through revenue it generates.

    At UConn Health, the largest source of income in FY26 is clinical care at 72.5%. At UConn’s Storrs and regional campuses, the largest source of income in FY26 is student tuition and fees at 57%.

    UConn already had committed to leaving its tuition rates flat in FY26 before the new state allocation numbers were determined and does not intend to reverse that decision. Separately, fees that pay for housing, dining, and various student services will increase modestly to pay for those enterprises.

    The cost-cutting initiatives, efforts to identify new revenue sources, increasing enrollment from higher-paying out-of-state and international students, and other measures will all be critical in the coming budget year, UConn officials say.

    The University will also examine every individual account in which unspent funds have been held as part of UConn’s overall reserves and, where possible and appropriate, will consolidate them to use as one-time spending to help fill gaps.

    “These dollars are not held in a central pool, but are in hundreds of accounts and budget lines throughout the institution that are used to fund our operations, meet upcoming needs, maintain our bond rating, and invest in the future of our university,” wrote President Radenka Maric, Provost Anne D’Alleva, and Vice President for Research Pamir Alpay in a message to the community on June 23.

    “Much of these funds are already committed for specific purposes. Using these funds to close short-term deficits will create new financial problems that didn’t exist previously and new unmet needs throughout the institution,” they wrote.

    “And if these one-time funds become exhausted, they do not automatically replenish, and structural deficits will remain. Despite the very real challenges and hardships this will cause, our current financial picture does not leave us with a reasonable alternative.”

    With the FY27 projected deficits even higher than those in FY26, UConn officials say efforts to reduce costs and increase revenue will be needed moving forward while the institution continues to prioritize student success, academic strength, and research impact.

    “Please know that we are not alone in having to make these difficult decisions. Every large research university across the nation is being forced to take similar steps,” Maric, D’Alleva, and Alpay added in their message.

    Overall, Maric says, UConn will continue to focus over the next three to five years on core operational priorities: continuous improvement and effectiveness, improving the enrollment outlook, increasing the academic and research profile, supporting a championship culture and competitiveness in UConn Athletics; and advancing fundraising and engagement efforts at the UConn Foundation.

    “In this and everything we do, we will ask ourselves: Is this helping our graduation rate? Is this supporting student success?” Maric said Tuesday.

    UConn has had a long-standing commitment to providing student financial aid as part of that work and set aside 16.5% of its tuition-generated revenue for those uses – voluntarily higher than the 15% minimum established by the state.

    In the coming fiscal year, UConn will increase institutionally funded financial aid by 10.6% as part of its work to attract and retain students, of whom 85% receive at least one form of financial aid.

    In addition to approving the operating budget, the Board of Trustees also adopted the capital improvement budgets for UConn Storrs / regionals and UConn Health for FY26.

    Those allocations are limited to specific building and infrastructure projects and cannot be shifted to help allay the pressures on the operating fund.

    At the Storrs and regional campuses, the $175 million capital budget for FY26 will fund a variety of projects that include a major renovation of Gampel Pavilion; a portion of the cost of construction of a new nursing building; improvements in various residence halls; and other critical deferred maintenance and infrastructure repair projects.

    The UConn capital budget consists of $128 million in bond funds for projects under the UCONN 2000 program; $8 million of state general obligation bond proceeds; and $39 million from student fees collected to support infrastructure maintenance and residential life facility improvements.

    At UConn Health, the $58.4 million capital budget for FY26 is funded through $28 million in state general obligation bond funds and $30.4 million generated by UConn Health, which has more than doubled its clinical care revenue over the past 10 years.

    Like at UConn Storrs and regional campuses, the capital funds will be directed to UConn Health’s critical deferred maintenance and infrastructure repair projects as well as improvements to clinical spaces that enable revenue growth.

    MIL OSI USA News –

  • MIL-OSI USA: At HELP Hearing, Senator Murray Presses CDC Nominee on Commitment to Scientific Integrity, Vaccine Access, as RFK Jr. Fires ACIP Members, Pushes Vaccine Conspiracies

    US Senate News:

    Source: United States Senator for Washington State Patty Murray

    ICYMI: Murray Calls for Kennedy to Reinstate Fired ACIP Members or Delay Meeting Until New Members Appropriately Vetted

    Senator Murray, along with Senator Richard Burr (R-NC), authored the PREVENT Pandemics Act that made the CDC Director a Senate confirmed position for the first time starting this year

    Dr. Monarez on ACIP members: “If they have not gone through an ethics approval process, they shouldn’t be participating in the meetings”

    ***WATCH: Murray’s questioning of Dr. Monarez***

    Washington, D.C. – Today—during a Senate Health, Education, Labor, and Pensions (HELP) Committee hearing on the nomination for Director of the Centers for Disease Control and Prevention (CDC)—Senator Murray, senior member and former Chair of the Senate HELP Committee, questioned nominee Dr. Susan Monarez on Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. firing of all 17 members of the CDC’s Advisory Committee for Immunization Practices (ACIP) and replacing them with 8 new unvetted members just two weeks ago, pressing Dr. Monarez on the need for the new ACIP members to go through a thorough ethics review process before meeting today. Murray also raised alarm over Secretary Kennedy’s move to bring in Lyn Redwood, the leader of the anti-vaccine group founded by Secretary Kennedy, to give a presentation on thimerosal in vaccines at the ACIP meeting this week—furthering RFK Jr.’s debunked claims that the preservative used in vaccines causes autism. Senator Murray also pressed Dr. Monarez on the importance of ACIP in maintaining no-cost access to evidence-based vaccines for children and families, and how ACIP recommendation changes could force families to pay out of pocket for vaccines—or forgo vaccination.

    Yesterday, Senator Murray called on Secretary Kennedy to reinstate the ACIP members he fired without cause, or delay this week’s meeting until the new members have been appropriately vetted. Earlier this month, Senator Murray held a press call with Dr. Helen Chu of Washington state, one of the 17 ACIP members abruptly fired by Secretary Kennedy, laying out how Secretary Kennedy’s purge of the Committee threatened public health and vaccine confidence.

    Senator Murray was a vocal critic of President Trump’s first pick for CDC Director, Dave Weldon. The CDC Director is a Senate-confirmed position for the first time this year thanks to a provision in Senator Murray’s bipartisan PREVENT Pandemics Act, which she negotiated and passed with former Senator Richard Burr (R-NC) in 2022.

    [ACIP MEMBER QUALIFICATION]

    Senator Murray began by questioning Dr. Monarez on the appointment process of members of CDC’s Advisory Committee on Immunization Practices (ACIP), as RFK Jr. appointed members with seemingly no vetting process, “Three weeks ago, Secretary Kennedy abruptly fired all 17 members of the ACIP. And then, he appointed 8 new, unvetted members—many of whom are known vaccine skeptics—and as we all know the Committee is starting today to vote on vaccine recommendations. As of last night, they’re down to just 7 members. I wanted to ask you, do you agree that any new ACIP members should have to go through a thorough ethics review process before meeting?”

    Dr. Monarez replied, “The members of the ACIP do need to go through a thorough ethics review before they are allowed to participate in those critical meetings.”

    Senator Murray pressed, “So, if that ethics review process was not complete before the Committee met today—do you think any vaccine recommendations from this week’s meetings should be valid?”

    “My understanding is that to convene the ACIP meetings, there needs to be a quorum of participants,” replied Dr. Monarez.

    Senator Murray reiterated her question, “You just said they should through the ethics vetting before meeting, they are meeting today without that ethics review process. Should they make recommendations today? Should they be valid?”

    Dr. Monarez answered, “I’m not familiar whether or not the members that are participating in the meeting this week have or have not gone through the ethics review necessary to allow them to participate in those meetings.”

    “If it is known that they have not gone through the ethics process and they issue recommendations, would you accept them as valid?” asked Senator Murray.

    “If they have not gone through an ethics approval process, they shouldn’t be participating in the meetings,” said Dr. Monarez.

    Senator Murray continued, “I would agree with that. And I know Chair Cassidy has expressed concerns about that as well. These affect millions of people, and it’s not just the members that I’m concerned about. Secretary Kennedy is bringing anti-vaccine conspiracy theorists from his former organization into that crucial vaccine meeting. Lyn Redwood, who is from the Children’s Health Defense, is scheduled to give a presentation on thimerosal in vaccines, to further RFK’s debunked claims that it causes autism, and she cited a study that does not exist. And after that was pointed out, CDC uploaded a new presentation. But let me ask you, do you think it is acceptable for a known conspiracy theorist who cites made-up sources to be presenting at CDC’s ACIP meeting and advising on vaccine recommendations?”

    Dr. Monarez replied, “I’m not familiar with the person you have identified. The ACIP is a public meeting and members of the public are in a position to be able to present what should be scientific and evidence-based information. And members of the ACIP should listen to that information and be able to evaluate the veracity of the data that is being discussed.”

    “The CDC Director makes the decision on whether a vaccine should be recommended to the public and does not have to follow recommendations passed by ACIP. What will you do if the Committee votes to remove vaccines from the vaccine schedule—or to not approve new ones—in opposition to clear, established science?” Senator Murray asked.

    “If I’m confirmed as a CDC Director, I will be an active listener and will be very interested in the discussions that take place at the ACIP meetings. I will be looking at how the ACIP members are able to evaluate this complex scientific information and the statistical analysis that goes into the risk benefit associated with that,” Dr. Monarez responded.

    Senator Murray said, “I appreciate that long answer there, but I have to say, many of us are very deeply concerned about the recommendations because they impact millions of people as I said. But they also translate directly into which vaccines get covered by insurance—and which vaccines are then accessible to patients.”

    [VACCINE COVERAGE]

    Senator Murray then questioned Dr. Monarez on access to vaccines as RFK Jr. attempts to obstruct coverage for millions of Americans, “Secretary Kennedy has spread really blatant disinformation about vaccines, and undermined the established science by pretending families need to do their own research on vaccine safety. Secretary Kennedy recently decided to revoke COVID vaccine recommendations for children and pregnant women, meaning that their insurance may now not cover the cost of their vaccines.”

    “Do you think ‘leaving it up to the parents’ or the individual, if the ‘choice’ they are left with is to spend hundreds or thousands of dollars just to get one vaccine that was previously free, is the right way to go here?” asked Senator Murray.

    Dr. Monarez said, “I think we need to make sure that we are providing transparent and clear, effective communications about the benefits and the risks associated with vaccines so parents can make informed decision-making for themselves, their children, their families.”

    Senator Murray concluded, “Well, it is hard to know if it’s informed if you have ACIP members who are listening to somebody who is a vaccine conspiracy theorist that has been debunked. And I just want to make this clear, when ACIP pulls its recommendation or refuses to recommend an evidence-based vaccine, a lot more kids and a lot more families will not get vaccinated. They will not be able to afford it. And that is the reality.”

    _______________

    Senator Murray forcefully opposed the nomination of notorious anti-vaccine activist RFK Jr. to be Secretary of HHS, and she has long worked to combat vaccine skepticism and highlight the importance of scientific research and vaccines. Murray was also a leading voice against the nomination of Dr. Dave Weldon to lead CDC, repeatedly speaking up about her serious concerns with the nominee immediately after their meeting. In 2019, Senator Murray co-led a bipartisan hearing in the HELP Committee on vaccine hesitancy and spoke about the importance of addressing vaccine skepticism and getting people the facts they need to keep their families and communities safe and healthy. Ahead of the 2019 hearing, as multiple states were facing measles outbreaks in under-vaccinated areas, Murray sent a bipartisan letter with former HELP Committee Chair Lamar Alexander pressing Trump’s CDC Director and HHS Assistant Secretary for Health on their efforts to promote vaccination and vaccine confidence.

    Senator Murray has been a leading voice in Congress against RFK Jr.’s dismantling of HHS and attacks on America’s public health infrastructure, raising the alarm over HHS’ unilateral reorganization plan and slamming the closure of the HHS Region 10 office in Seattle and the CDC’s National Institute for Occupational Safety and Health (NIOSH) Spokane Research Laboratory. Senator Murray has sent oversight letters and hosted numerous press conferences and events to lay out how the administration’s reckless gutting of HHS is risking Americans’ health and safety and will set our country back decades, and lifting up the voices of HHS employees who were fired for no reason and through no fault of their own.

    MIL OSI USA News –

  • MIL-OSI USA: At HELP Hearing, Senator Murray Presses CDC Nominee on Commitment to Scientific Integrity, Vaccine Access, as RFK Jr. Fires ACIP Members, Pushes Vaccine Conspiracies

    US Senate News:

    Source: United States Senator for Washington State Patty Murray

    ICYMI: Murray Calls for Kennedy to Reinstate Fired ACIP Members or Delay Meeting Until New Members Appropriately Vetted

    Senator Murray, along with Senator Richard Burr (R-NC), authored the PREVENT Pandemics Act that made the CDC Director a Senate confirmed position for the first time starting this year

    Dr. Monarez on ACIP members: “If they have not gone through an ethics approval process, they shouldn’t be participating in the meetings”

    ***WATCH: Murray’s questioning of Dr. Monarez***

    Washington, D.C. – Today—during a Senate Health, Education, Labor, and Pensions (HELP) Committee hearing on the nomination for Director of the Centers for Disease Control and Prevention (CDC)—Senator Murray, senior member and former Chair of the Senate HELP Committee, questioned nominee Dr. Susan Monarez on Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. firing of all 17 members of the CDC’s Advisory Committee for Immunization Practices (ACIP) and replacing them with 8 new unvetted members just two weeks ago, pressing Dr. Monarez on the need for the new ACIP members to go through a thorough ethics review process before meeting today. Murray also raised alarm over Secretary Kennedy’s move to bring in Lyn Redwood, the leader of the anti-vaccine group founded by Secretary Kennedy, to give a presentation on thimerosal in vaccines at the ACIP meeting this week—furthering RFK Jr.’s debunked claims that the preservative used in vaccines causes autism. Senator Murray also pressed Dr. Monarez on the importance of ACIP in maintaining no-cost access to evidence-based vaccines for children and families, and how ACIP recommendation changes could force families to pay out of pocket for vaccines—or forgo vaccination.

    Yesterday, Senator Murray called on Secretary Kennedy to reinstate the ACIP members he fired without cause, or delay this week’s meeting until the new members have been appropriately vetted. Earlier this month, Senator Murray held a press call with Dr. Helen Chu of Washington state, one of the 17 ACIP members abruptly fired by Secretary Kennedy, laying out how Secretary Kennedy’s purge of the Committee threatened public health and vaccine confidence.

    Senator Murray was a vocal critic of President Trump’s first pick for CDC Director, Dave Weldon. The CDC Director is a Senate-confirmed position for the first time this year thanks to a provision in Senator Murray’s bipartisan PREVENT Pandemics Act, which she negotiated and passed with former Senator Richard Burr (R-NC) in 2022.

    [ACIP MEMBER QUALIFICATION]

    Senator Murray began by questioning Dr. Monarez on the appointment process of members of CDC’s Advisory Committee on Immunization Practices (ACIP), as RFK Jr. appointed members with seemingly no vetting process, “Three weeks ago, Secretary Kennedy abruptly fired all 17 members of the ACIP. And then, he appointed 8 new, unvetted members—many of whom are known vaccine skeptics—and as we all know the Committee is starting today to vote on vaccine recommendations. As of last night, they’re down to just 7 members. I wanted to ask you, do you agree that any new ACIP members should have to go through a thorough ethics review process before meeting?”

    Dr. Monarez replied, “The members of the ACIP do need to go through a thorough ethics review before they are allowed to participate in those critical meetings.”

    Senator Murray pressed, “So, if that ethics review process was not complete before the Committee met today—do you think any vaccine recommendations from this week’s meetings should be valid?”

    “My understanding is that to convene the ACIP meetings, there needs to be a quorum of participants,” replied Dr. Monarez.

    Senator Murray reiterated her question, “You just said they should through the ethics vetting before meeting, they are meeting today without that ethics review process. Should they make recommendations today? Should they be valid?”

    Dr. Monarez answered, “I’m not familiar whether or not the members that are participating in the meeting this week have or have not gone through the ethics review necessary to allow them to participate in those meetings.”

    “If it is known that they have not gone through the ethics process and they issue recommendations, would you accept them as valid?” asked Senator Murray.

    “If they have not gone through an ethics approval process, they shouldn’t be participating in the meetings,” said Dr. Monarez.

    Senator Murray continued, “I would agree with that. And I know Chair Cassidy has expressed concerns about that as well. These affect millions of people, and it’s not just the members that I’m concerned about. Secretary Kennedy is bringing anti-vaccine conspiracy theorists from his former organization into that crucial vaccine meeting. Lyn Redwood, who is from the Children’s Health Defense, is scheduled to give a presentation on thimerosal in vaccines, to further RFK’s debunked claims that it causes autism, and she cited a study that does not exist. And after that was pointed out, CDC uploaded a new presentation. But let me ask you, do you think it is acceptable for a known conspiracy theorist who cites made-up sources to be presenting at CDC’s ACIP meeting and advising on vaccine recommendations?”

    Dr. Monarez replied, “I’m not familiar with the person you have identified. The ACIP is a public meeting and members of the public are in a position to be able to present what should be scientific and evidence-based information. And members of the ACIP should listen to that information and be able to evaluate the veracity of the data that is being discussed.”

    “The CDC Director makes the decision on whether a vaccine should be recommended to the public and does not have to follow recommendations passed by ACIP. What will you do if the Committee votes to remove vaccines from the vaccine schedule—or to not approve new ones—in opposition to clear, established science?” Senator Murray asked.

    “If I’m confirmed as a CDC Director, I will be an active listener and will be very interested in the discussions that take place at the ACIP meetings. I will be looking at how the ACIP members are able to evaluate this complex scientific information and the statistical analysis that goes into the risk benefit associated with that,” Dr. Monarez responded.

    Senator Murray said, “I appreciate that long answer there, but I have to say, many of us are very deeply concerned about the recommendations because they impact millions of people as I said. But they also translate directly into which vaccines get covered by insurance—and which vaccines are then accessible to patients.”

    [VACCINE COVERAGE]

    Senator Murray then questioned Dr. Monarez on access to vaccines as RFK Jr. attempts to obstruct coverage for millions of Americans, “Secretary Kennedy has spread really blatant disinformation about vaccines, and undermined the established science by pretending families need to do their own research on vaccine safety. Secretary Kennedy recently decided to revoke COVID vaccine recommendations for children and pregnant women, meaning that their insurance may now not cover the cost of their vaccines.”

    “Do you think ‘leaving it up to the parents’ or the individual, if the ‘choice’ they are left with is to spend hundreds or thousands of dollars just to get one vaccine that was previously free, is the right way to go here?” asked Senator Murray.

    Dr. Monarez said, “I think we need to make sure that we are providing transparent and clear, effective communications about the benefits and the risks associated with vaccines so parents can make informed decision-making for themselves, their children, their families.”

    Senator Murray concluded, “Well, it is hard to know if it’s informed if you have ACIP members who are listening to somebody who is a vaccine conspiracy theorist that has been debunked. And I just want to make this clear, when ACIP pulls its recommendation or refuses to recommend an evidence-based vaccine, a lot more kids and a lot more families will not get vaccinated. They will not be able to afford it. And that is the reality.”

    _______________

    Senator Murray forcefully opposed the nomination of notorious anti-vaccine activist RFK Jr. to be Secretary of HHS, and she has long worked to combat vaccine skepticism and highlight the importance of scientific research and vaccines. Murray was also a leading voice against the nomination of Dr. Dave Weldon to lead CDC, repeatedly speaking up about her serious concerns with the nominee immediately after their meeting. In 2019, Senator Murray co-led a bipartisan hearing in the HELP Committee on vaccine hesitancy and spoke about the importance of addressing vaccine skepticism and getting people the facts they need to keep their families and communities safe and healthy. Ahead of the 2019 hearing, as multiple states were facing measles outbreaks in under-vaccinated areas, Murray sent a bipartisan letter with former HELP Committee Chair Lamar Alexander pressing Trump’s CDC Director and HHS Assistant Secretary for Health on their efforts to promote vaccination and vaccine confidence.

    Senator Murray has been a leading voice in Congress against RFK Jr.’s dismantling of HHS and attacks on America’s public health infrastructure, raising the alarm over HHS’ unilateral reorganization plan and slamming the closure of the HHS Region 10 office in Seattle and the CDC’s National Institute for Occupational Safety and Health (NIOSH) Spokane Research Laboratory. Senator Murray has sent oversight letters and hosted numerous press conferences and events to lay out how the administration’s reckless gutting of HHS is risking Americans’ health and safety and will set our country back decades, and lifting up the voices of HHS employees who were fired for no reason and through no fault of their own.

    MIL OSI USA News –

  • MIL-OSI Europe: REPORT on European technological sovereignty and digital infrastructure – A10-0107/2025

    Source: European Parliament

    MOTION FOR A EUROPEAN PARLIAMENT RESOLUTION

    on European technological sovereignty and digital infrastructure

    (2025/2007(INI))

    The European Parliament,

    – having regard to the Treaty on the Functioning of the European Union (TFEU), in particular Articles 173, 179 and 190 thereof,

    – having regard to the Commission communication of 29 January 2025 entitled ‘A Competitiveness Compass for the EU’ (COM(2025)0030),

    – having regard to the Commission communication of 11 February 2025 entitled ‘Commission work programme 2025: Moving forward together: A Bolder, Simpler, Faster Union’ (COM(2025)0045),

    – having regard to Regulation (EU) 2023/1781 of the European Parliament and of the Council of 13 September 2023 establishing a framework of measures for strengthening Europe’s semiconductor ecosystem[1] (the Chips Act),

    – having regard to Directive (EU) 2022/2555 of the European Parliament and of the Council of 14 December 2022 on measures for a high common level of cybersecurity across the Union[2] (NIS 2 Directive),

    – having regard to the detailed report by the European Union Agency for Cybersecurity (ENISA) entitled ‘Foresight Cybersecurity Threats For 2030 – Update 2024’, published in March 2024,

    – having regard to Regulation (EU) 2024/2847 of the European Parliament and of the Council of 23 October 2024 on horizontal cybersecurity requirements for products with digital elements[3] (the Cyber Resilience Act),

    – having regard to Regulation (EU) 2019/881 of the European Parliament and of the Council of 17 April 2019 on ENISA (the European Union Agency for Cybersecurity) and on information and communications technology cybersecurity certification and repealing Regulation (EU) No 526/2013[4] (the Cybersecurity Act),

    – having regard to Regulation (EU) 2025/38 of the European Parliament and of the Council of 19 December 2024 laying down measures to strengthen solidarity and capacities in the Union to detect, prepare for and respond to cyber threats and incidents[5] (the Cyber Solidarity Act),

    – having regard to Regulation (EU) 2025/37 of the European Parliament and of the Council of 19 December 2024 amending Regulation (EU) 2019/881 as regards managed security services[6],

    – having regard to the Commission White Paper of 21 February 2024 entitled ‘How to master Europe’s digital infrastructure needs?’ (COM(2024)0081),

    – having regard to Mario Draghi’s report of 9 September 2024 entitled ‘The future of European competitiveness’,

    – having regard to Enrico Letta’s report of 17 April 2024 entitled ‘Much more than a market’,

    – having regard to the Commission communication of 2 July 2024 entitled ‘State of the Digital Decade 2024’ (COM(2024)0260),

    – having regard to Decision (EU) 2022/2481 of the European Parliament and of the Council of 14 December 2022 establishing the Digital Decade Policy Programme 2030[7],

    – having regard to Regulation (EU) 2024/903 of the European Parliament and of the Council of 13 March 2024 laying down measures for a high level of public sector interoperability across the Union[8] (the Interoperable Europe Act),

    – having regard to Directive (EU) 2019/1024 of the European Parliament and of the Council of 20 June 2019 on open data and the re-use of public sector information (recast)[9],

    – having regard to Regulation (EU) 2024/795 of the European Parliament and of the Council of 29 February 2024 establishing the Strategic Technologies for Europe Platform (STEP), and amending Directive 2003/87/EC and Regulations (EU) 2021/1058, (EU) 2021/1056, (EU) 2021/1057, (EU) No 1303/2013, (EU) No 223/2014, (EU) 2021/1060, (EU) 2021/523, (EU) 2021/695, (EU) 2021/697 and (EU) 2021/241[10],

    – having regard to Regulation (EU) 2023/2854 of the European Parliament and of the Council of 13 December 2023 on harmonised rules on fair access to and use of data and amending Regulation (EU) 2017/2394 and Directive (EU) 2020/1828[11] (the Data Act),

    – having regard to Regulation (EU) 2024/1309 of the European Parliament and of the Council of 29 April 2024 on measures to reduce the cost of deploying gigabit electronic communications networks, amending Regulation (EU) 2015/2120 and repealing Directive 2014/61/EU[12] (the Gigabit Infrastructure Act),

    – having regard to Regulation (EU) 2024/1689 of the European Parliament and of the Council of 13 June 2024 laying down harmonised rules on artificial intelligence[13] (the Artificial Intelligence Act),

    – having regard to Regulation (EU) 2021/1153 of the European Parliament and of the Council of 7 July 2021 establishing the Connecting Europe Facility (CEF) and repealing Regulations (EU) No 1316/2013 and (EU) No 283/2014[14],

    – having regard to Regulation (EU) 2021/694 of the European Parliament and of the Council of 29 April 2021 establishing the Digital Europe Programme and repealing Decision (EU) 2015/2240[15],

    – having regard to Regulation (EU) 2021/695 of the European Parliament and of the Council of 28 April 2021 establishing Horizon Europe – the Framework Programme for Research and Innovation, laying down its rules for participation and dissemination, and repealing Regulations (EU) No 1290/2013 and (EU) No 1291/2013[16],

    – having regard to Regulation (EU) 2021/696 of the European Parliament and of the Council of 28 April 2021 establishing the Union Space Programme and the European Union Agency for the Space Programme[17],

    – having regard to Regulation (EU) 2023/588 of the European Parliament and of the Council of 15 March 2023 establishing the Union Secure Connectivity Programme for the period 2023-2027[18],

    – having regard to Council Regulation (EU) 2021/2085 of 19 November 2021 establishing the Joint Undertakings under Horizon Europe and repealing Regulations (EC) No 219/2007, (EU) No 557/2014, (EU) No 558/2014, (EU) No 559/2014, (EU) No 560/2014, (EU) No 561/2014 and (EU) No 642/2014[19],

    – having regard to Council Regulation (EU) 2021/1173 of 13 July 2021 on establishing the European High Performance Computing Joint Undertaking and repealing Regulation (EU) 2018/1488[20],

    – having regard to Council Regulation (EU) 2024/1732 of 17 June 2024 amending Regulation (EU) 2021/1173 as regards a EuroHPC initiative for start-ups in order to boost European leadership in trustworthy artificial intelligence[21],

    – having regard to Directive (EU) 2018/1972 of the European Parliament and of the Council of 11 December 2018 establishing the European Electronic Communications Code (recast)[22],

    – having regard to Regulation (EU) 2024/1183 of the European Parliament and of the Council of 11 April 2024 amending Regulation (EU) No 910/2014 as regards establishing the European Digital Identity Framework[23],

    – having regard to the joint communication from the Commission and the High Representative of the Union for Foreign Affairs and Security Policy of 21 February 2025 to the European Parliament and the Council entitled ‘EU Action Plan on Cable Security’ (JOIN(2025)0009),

    – having regard to the Commission communication of 29 January 2020 entitled ‘Secure 5G deployment in the EU – Implementing the EU toolbox’ (COM(2020)0050),

    – having regard to the European Declaration on Digital Rights and Principles for the Digital Decade, which commits ‘to promote a European way for the digital transformation, putting people at the centre’,

    – having regard to the Commission communication of 30 December 2021 entitled ‘Criteria for the analysis of the compatibility with the internal market of State aid to promote the execution of important projects of common European interest’ (IPCEIs) (COM(2021)8481),

    – having regard to Rule 55 of its Rules of Procedure,

    – having regard to the report of the Committee on Industry, Research and Energy (A10-0107/2025),

    A. whereas technological sovereignty should be seen as the whole value chain from excellence in research to creating better competition and achieving greater European sovereignty;

    B. whereas the EU relies on non-EU countries for over 80 % of digital products, services, infrastructure and intellectual property;

    C. whereas a few technological companies hold concentrated power over key digital markets and control over underlying internet infrastructure, including operating systems, computing, artificial intelligence (AI), search engines, social media capacity, digital advertising and payment services;

    D. whereas our technological sovereignty will greatly depend on Europe’s ability to create the market conditions needed for European companies to flourish and compete with each other, thereby increasing the quality of their products;

    E. whereas the EU is at risk of failing to meet its digital decade targets and objectives, including the adoption of cloud, big data and AI;

    F. whereas European firms contribute a minor share to global research and development (R&D) in software, internet technologies and electronics, while the United States and China lead in these sectors;

    G. whereas the Commission’s Digital Compass, Digital Decade Policy Programme, and Competitiveness Compass are essential frameworks for strengthening Europe’s digital ecosystem, securing technological leadership and ensuring long-term economic resilience;

    H. whereas digital infrastructure is composed of hardware elements related to connectivity, including fibre, 5G and 6G, submarine cables, satellites and spectrum, and computing, including semiconductors, data centres, HPC and quantum technologies, and of software elements including identity solutions, the Internet of Things, and cloud and AI systems, as well as the intermediary layer including advertising, search engines, payments and communication systems;

    I. whereas the EU’s competitiveness will increasingly depend on the digitalisation of all sectors, supported by resilient, safe and trustworthy digital infrastructure; notes, in this context, that the digital single market is a vital asset as it can enable companies to grow and scale up;

    J. whereas the full potential of the digital single market remains untapped, with intra-EU trade in digital services representing just 8 % of GDP, which is significantly lower than the 25 % for trade in digital goods;

    K. whereas the availability of eID schemes and digital public services and access to e-Health records are increasing, but there are still significant gaps in the provision of privacy preserving, fully user-centric, accessible and sovereign digital public services among Member States due to differences in the adoption of eID;

    L. whereas eID is currently available to 93 % of the EU’s population, but achieving 100 % of digital public services for citizens and businesses by 2030 remains challenging;

    M. whereas interoperability and interconnectedness would enhance the competitiveness of the European economy and might benefit from policies such as open-source first and public money, public code, and the implementation of common and open standards;

    N. whereas digital infrastructure is of key importance for EU industry, including the automotive industry and the possible development of connected and autonomous  vehicles; whereas robust data and communications infrastructure is needed to support a secure ecosystem for connected and autonomous vehicles;

    O. whereas fibre-optic networks form one of the backbones of the EU’s digital infrastructure, enabling high-speed internet, 5G networks and future technological improvements;

    P. whereas the EU is behind on the roll-out of 5G to meet its 2030 targets, with still limited fibre coverage of only about 64 % of European households being included;

    Q. whereas investment needs in state-of-the-art connectivity in the EU are immense;

    R. whereas resolving challenges related to access to land and grids is key to the successful deployment of digital infrastructure;

    S. whereas the EU GOVSATCOM initiative aims to ensure the long-term availability of secure, reliable and cost-effective governmental satellite communication services for EU and national public authorities that manage critical security infrastructure and missions;

    T. whereas chips play a crucial role in increasing the technological competitiveness and resilience of Europe;

    U. whereas the Commission’s Competitiveness Compass, the Clean Industrial Deal and the 2025 Commission Work Programme make little to no mention of semiconductor technologies despite their critical importance for the EU’s industrial ambition;

    V. whereas the Chips Act was an ad hoc adaptation mechanism aimed at addressing certain challenges regarding semiconductor shortages; whereas its areas of action are mostly limited to advanced semiconductors; whereas EU engagement on legacy semiconductors is insufficient; whereas the revision of the Chips Act is expected in September 2026;

    W. whereas the existing European regional clusters in the semiconductor sector have a role to play and should be further strengthened;

    X. whereas processors, memory technologies, graphics processing units (GPUs), and quantum chips are critical to Europe’s digital infrastructure and supply chain security;

    Y. whereas cloud services are fundamental to a wide range of computational activities and computing services that have become an essential enabler of competitiveness;

    Z. whereas federated models could enhance the competitiveness of the EU market by facilitating the emergence of significant European alternatives, building on local market expertise and presence;

    AA. whereas large-scale AI infrastructure, such as AI gigafactories, is essential for enabling open and collaborative development of the most complex AI models;

    AB. whereas the AI value chain is still under development and tackling the development of AI models is only part of it; whereas European AI solutions may be developed using Europe’s public and private computing infrastructure, driving innovation, and start-ups and small companies should be in particular beneficiaries of access to public computing infrastructure;

    AC. whereas AI models that can be run on widely available hardware at moderate costs allow a greater number of actors to shape how AI systems are created and used, providing more immediate value in applications and enabling a more democratic use of AI;

    AD. whereas at the moment, the roll-out, marketing and deployment of AI is often shaped by a small number of big tech companies; whereas some AI features are not being rolled out in the EU at the same time as in non-EU countries, creating a competitive disadvantage for European businesses and consumers;

    AE. whereas data centres are an essential part of an advanced digital society, as enablers of distributed processing and effective data storage;

    AF. whereas trusted capacity and availability of data storage is essential for European resilience and development; whereas most data centres in Europe are not owned by European companies;

    AG. whereas building and operating large-scale data centres requires substantial investment;

    AH. whereas around 9 % of global electricity consumption results from data centres, cloud services and connectivity;

    AI. whereas submarine cables are critical infrastructure for global connectivity, economic stability and security, carrying over 99 % of international communications through them, and they remain vulnerable to physical damage, cyberthreats and geopolitical risks;

    AJ. whereas secure and resilient digital infrastructure is crucial, particularly considering the increasing number of cyberattacks against the EU, its Member States and its industry and society;

    AK. whereas the EU toolbox for 5G security is important for preventing cyberespionage and strengthening the resilience of supply chains in the EU’s digital infrastructure;

    AL. whereas 21 % of businesses cite compliance and legal uncertainties as a barrier to digital investment;

    AM. whereas the ‘one in, one out’ approach ensures that all burdens introduced by Commission initiatives are considered and that administrative burdens are offset by removing burdens of equivalent value in the same policy area;

    AN. whereas the energy consumption challenges in AI, cloud and quantum computing, as well as data centres, require the integration of sustainability into digital infrastructure strategies;

    AO. whereas data centre power consumption is projected to nearly triple by the end of this decade, increasing from approximately 62 terawatt-hours (TWh) today to more than 150 TWh, thus escalating from 2 % to 5 % of total European power consumption;

    AP. whereas the digital skills gap remains a major concern, with only 54 % of European citizens possessing at least basic digital skills – well below the 80 % target set in the digital decade policy programme;

    AQ. whereas the shortage of ICT professionals in the EU is projected to reach 12 million by 2030, falling significantly short of the EU’s target of 20 million skilled workers;

    AR. whereas the 2024 State of the Digital Decade report and the Draghi report both stress the urgent need to invest in digital and science, technology, engineering and mathematics (STEM) skills to preserve Europe’s technological capabilities and global competitiveness;

    AS. whereas 60 % of EU companies report difficulties in recruiting skilled workers in areas such as AI, cybersecurity and clean technologies, posing a significant barrier to innovation, competitiveness and the green and digital transitions;

    AT. whereas current labour market developments, including global lay-offs and political instability outside the EU, create an opportunity to attract high-skilled digital talent to the EU;

    AU. whereas increasing competitiveness and resilience require appropriate funding; whereas public funding can act as a catalyst and private investment and competitive market forces are key for the long-term development of digital infrastructure;

    AV. whereas a robust, agile and excellence-driven research and innovation (R&I) ecosystem is essential to ensure the EU’s global competitiveness and leadership in strategic technologies, such as quantum and AI;

    AW. whereas standardisation is at the core of genuine European digital and technological sovereignty; whereas the importance of standards is growing due to increasing technological competition across the world, particularly with the United States and China;

    AX. whereas the EU is committed to negotiating comprehensive digital trade agreements (DTAs) to promote secure, resilient and competitive digital infrastructure development with partner countries;

    AY. whereas the Commission has announced landmark DTAs with South Korea and Singapore, setting an important precedent for future agreements;

    AZ. whereas Parliament and the Council have agreed on the ‘EU horizontal provisions on Cross-border data flows and protection of personal data and privacy in the Digital Trade Title of EU trade agreements’, which was endorsed by the Commission and remains an important tool in relation to digital trade and the establishment of new DTAs;

    General introduction

    1. Underlines that European sovereignty is the ability to build capacity, resilience and security by reducing strategic dependencies, preventing reliance on foreign actors and single service providers, and safeguarding critical technologies and infrastructure; calls for the development of a comprehensive risk assessment framework to monitor and address dependencies across the digital value chain; underlines that such a framework should serve as a basis for ensuring EU preparedness and resilience by enhancing European industrial policy and boosting domestic R&D and manufacturing capabilities in strategic technologies;

    2. Believes that technological sovereignty is the capacity to design, develop and scale up digital technologies needed for the competitiveness of our economy, the welfare of our citizens and the EU’s open strategic autonomy in a globalised world; believes that this includes ensuring the EU’s ability to make autonomous decisions, engaging with trusted non-EU countries and entities, diversifying and strengthening supply chains and promoting the concept of openness and interoperability to ensure that Europe remains an attractive hub for investment;

    3. Recognises the increasing concentration of power in non-EU companies, which constrains Europe’s ability to innovate, compete and maintain control over its digital economy, society and democracy; is concerned by excessive dependencies on non-EU actors in critical areas such as cloud infrastructure, semiconductors, AI and cybersecurity – where market concentration and foreign control threaten to undermine Europe’s competitiveness, democratic resilience and security;

    4. Believes that the EU’s industrial tech ambitions should focus on the key strategic technologies of the future, such as semiconductor technologies or quantum, that contribute to the EU’s open strategic autonomy and are essential for our green, digital and defence transitions;

    5. Recognises the shift in the geopolitical landscape and the resulting opportunity for market demand for European products and services; sees this as a window of opportunity to position Europe as a global leader in trusted and secure digital solutions;

    6. Underlines the need to foster a supportive regulatory environment that encourages innovation, investment and the development of cutting-edge technologies in Europe, while protecting EU end users from the consequences of extraterritoriality;

    7. Recognises the need for a comprehensive European industrial policy for the digital ecosystem, integrating all relevant policy domains such as market access, standardisation, R&D, investment, trade and international cooperation; calls on the Commission to develop this comprehensive policy with the aim of reducing harmful strategic dependencies, strengthening domestic value chains and ensuring a secure, trustworthy and innovation-driven digital ecosystem that adheres to European values;

    8. Recalls that the high-tech product and digital services markets depend heavily on external supply chains, posing risks to sovereignty and resilience; stresses the importance of boosting industrial capacity and technological expertise in emerging and disruptive technologies to support the EU’s open strategic autonomy;

    9. Emphasises that boosting Europe’s technological sovereignty in the era of rapid technological development requires enhancing innovation and commercialisation in order to build the necessary capabilities; highlights that Europe must transform itself into a globally attractive and agile business environment by reducing bureaucracy, enhancing regulatory predictability and fostering entrepreneurship and risk-taking;

    10. Recognises that open strategic autonomy and democratic resilience must be at the core of the Commission’s agenda and that a comprehensive approach must integrate procurement, funding and long-term institutional frameworks to establish sovereign digital infrastructure in critical domains;

    11. Calls on the Commission to analyse and establish a comprehensive list of critical dependencies in digital infrastructure and technologies, assessing, at minimum, storage services, identity and payment systems, communication platforms, as well as the software, protocols and standards that support them, and to propose measures to promote market access for products and services with a strong positive impact on the EU’s technological sovereignty, resilience and sustainability; believes, in that regard, that the use of specific award criteria in public procurement may be promoted in areas where such critical dependencies exist; believes that such criteria can help incentivise competition and strengthen European technological sovereignty by facilitating the procurement of European digital products and services, where possible;

    Digital public infrastructure

    12. Strongly believes that digital infrastructure is the backbone of our economy and that there should therefore be a base layer of digital public infrastructure (DPI) that ensures sovereignty and a competition-friendly market environment; observes that the market has not developed this base layer in many important areas, which has resulted in monopolies and reliance on foreign actors; underlines that in order to fill this gap, the EU should take the lead in creating a strong foundation for DPI by creating layers of digital technologies consisting of semiconductors, connectivity solutions, cloud infrastructure, software, data and AI; believes that European DPI should be founded on fair and competitive economic models and also use governance models where neither private companies nor governments maintain centralised control; is of the opinion that it should be built on common and open standards, embrace interoperability and interconnectedness, so as to prevent user and vendor ‘lock-ins’, and spur innovation by facilitating new market entrants, and that it should also ensure privacy and security by default;

    13. Believes that the deployment of DPI should be focused on areas where critical dependencies exist, as identified in the Commission’s comprehensive list; calls on the Commission to prepare a detailed and comprehensive plan for establishing European DPI by identifying technologies that are best suited to European action, and urges the Commission and the Member States to dedicate appropriate resources to deploying European DPI;

    14. Stresses that European DPI should be stimulated by coordinated action at EU level to ensure the presence and competitiveness of European providers as well as a competitive market environment; underlines that these objectives will not be achieved through regulation alone and will require significant public investment; recognises that the forthcoming multiannual financial framework (MFF) should therefore include additional funding for this purpose, focusing on EU added value and financing the base layer of European DPI;

    15. Recognises that as part of the forthcoming MFF, the EU must commit to increased spending to achieve technological sovereignty; underlines that this should include a dedicated envelope for the development and deployment of the DPI layers identified in the Commission’s comprehensive list, as well as additional funds to ensure a competition-friendly market environment in other digital areas;

    16. Believes that the funding under the forthcoming MFF should prioritise active capacity-building in key hardware, software and service areas, including high-performance computing, quantum computing, encryption and communication, connectivity, cloud, data, web and AI ecosystems, and digital libraries;

    17. Is of the opinion that European DPI should be based on EU values and remain open to like-minded non-EU partners; calls on the Commission and the Member States to sustain their efforts and add more impetus to the process with the UN Development Programme on DPI;

    18. Recognises e-government services as a key enabler of efficient, secure and accessible public service delivery, which should be designed to facilitate digital identification, government data sharing and public sector payments without distorting markets or undermining existing private sector solutions; emphasises that the EU’s approach to e-government services should focus on strengthening digital government-to-citizen and government-to-business interactions, while ensuring trust, interoperability and accessibility; believes, therefore, that secure and seamless access to public services requires a trustworthy e-identification framework and welcomes the announcement of a ‘business wallet’ aimed at significantly simplifying the interconnection between businesses and public authorities;

    19. Calls on the Commission to further develop public interest data platforms, enabling secure cross-border data sharing between public and private entities for use cases, in particular, in healthcare, urban planning and environmental monitoring; calls, furthermore, on the Commission to promote interoperability between public interest and industry-specific data platforms, ensuring the seamless flow of data while minimising administrative burdens; notes that this could be achieved by leveraging existing market-driven solutions that foster innovation, maintain trust and uphold privacy and security standards;

    20. Recognises that under the current legal framework, European citizens have the right to control their personal data and that data generated within the EU must be processed in accordance with EU law; stresses that safeguarding privacy and personal data is essential for building trust in the digital economy, allowing European consumers to engage with confidence, regardless of where their data is processed; highlights that European companies – particularly small and medium-sized enterprises (SMEs) – must be able to make use of data in a lawful, ethical and secure manner to drive sustainable growth and competitiveness;

    Digital infrastructure

    21. Highlights that digital infrastructure is the backbone of Europe’s economy and society and that its importance will continue to grow; calls on the Commission to include in the requested list of critical dependencies a comprehensive assessment of the composition of European digital infrastructure in order to adequately analyse the state of play, assess risks and coordinate action;

    22. Believes that in order to strengthen digital infrastructure, it is essential to implement capacity-building initiatives in critical areas at EU level; considers that these initiatives should focus on developing a base layer of public infrastructure, such as a network of AI gigafactories and a European web index model; is of the opinion that this base layer will empower companies to develop their business models and boost technological sovereignty; points to the digital solutions created by the EU, such as the EU digital identity, that can offer innovative infrastructure for the EU’s digital economy;

    23. Recognises the strategic importance of critical digital infrastructure and the need to strengthen their security and resilience; understands that critical digital infrastructure includes, but is not limited to, cables (terrestrial and submarine), cellular network towers, satellite communication systems, spectrum and radio equipment, cloud servers that contain sensitive information and data centres that process sensitive information, as well as certain software elements, including security software that protects critical networks and data centres;

    24. Highlights the need to ensure that this infrastructure falls under EU jurisdiction, meaning that it fully adheres to EU law; stresses the importance of privacy and security-by-design; calls on the Commission. therefore, to introduce legislation to mitigate risks posed by high-risk vendors from non-EU countries, including risks posed by foreign-controlled energy resource providers;

    25. Calls on the Commission, while preparing future legislative proposals and the forthcoming MFF, to concentrate efforts on deepening the single market, in line with the recommendations made in Enrico Letta’s report entitled ‘Much more than a market’ and in Mario Draghi’s report on ‘The future of European competitiveness’, with the aim of unlocking the potential of the digital single market;

    26. Takes note of the recommendations laid down in these two reports that the EU needs a paradigm shift from promoting connectivity in the EU to establishing a single market for electronic communications and connectivity; supports a simplified, harmonised and innovation-friendly telecommunications framework that ensures fair competition and the accessibility of infrastructure;

    27. Welcomes the Commission’s white paper on how to master Europe’s digital infrastructure needs, which outlines three pillars: creating the ‘3C Network’ – ‘Connected Collaborative Computing’, completing the digital single market, and secure and resilient digital infrastructure for Europe;

    28. Views the white paper and the subsequent consultation process as part of the preparation of the legislative initiatives planned for this term, including the Digital Networks Act; calls on the Commission to take a more holistic view of digital infrastructure throughout this process and to acknowledge that digital infrastructure comprises many elements beyond mere connectivity; underlines the need to accompany any new digital policy measure with an impact assessment;

    29. Urges the Commission to simplify and harmonise telecommunications rules as part of the forthcoming Digital Networks Act and the broader Digital Package;

    30. Calls on the Commission to introduce an EU cloud and AI development act to strengthen European data infrastructure and the promotion of European cloud providers; underlines that this act should aim to actively build a European single market for cloud and AI;

    31. Acknowledges that deploying cutting-edge digital infrastructure across the EU requires substantial investment and recognises that both public and private funding are essential for achieving this goal; expresses concern over the persistent shortage of venture capital and investment financing in Europe, which undermines technological sovereignty; calls on the Commission to significantly scale up public-private investment instruments, including venture capital, strategic platforms and dedicated funding tools for start-ups and scale-ups in critical technology sectors; highlights the importance of leveraging public procurement to support the deployment and scaling of open and interoperable digital solutions and of ensuring that private capital, competition and innovation become the main drivers of Europe’s digital transformation over the medium and long term;

    High-speed connectivity

    32. Is of the opinion that the upcoming Digital Networks Act must support the objective of providing all EU consumers with high-quality connectivity by 2030, especially in remote and rural areas, as well as removing administrative barriers for the roll-out of 5G, 6G and secure, high-speed broadband;

    33. Recognises the increasing convergence of telecommunications infrastructure with cloud and edge technologies, and sees the potential of open radio access networks to deliver advanced technological solutions, reduce costs and enhance the interoperability of connectivity; believes that the future of connectivity lies in the complementarity of diverse technologies such as 5G/6G, Wi-Fi and satellite, where seamless integration benefits both businesses and consumers;

    34. Recognises that with cloud and edge services at the core of their transformation, connectivity networks are evolving rapidly into platforms for innovation and will increasingly depend on cloud computing, AI, virtualisation and other technologies;

    35. Calls for ambitious targets in the development and innovation of wireless communication networks, acknowledging the need for a broad-based approach that includes cloud computing, AI, edge computing and quantum computing; emphasises that the innovation ecosystem for electronic communications, especially for vertically integrated telecoms, should remain market-driven, and insists that future regulatory measures be based on thorough, knowledge-based impact assessments of existing regulations;

    36. Recognises that competition between operators of all sizes remains a key driver of investment in connectivity networks; calls on the Member States to ensure that copper networks are switched off progressively in favour of fibre-optic or 5G technologies, in particular where regular maintenance or updates of the network are needed, thus ensuring that the shift is carried out in an attainable manner and allowing providers to plan logistically and financially in advance;

    37. Stresses that all consumers in the EU should have access to adequate quality, reliable and affordable connectivity, thus contributing to increased demand for connectivity services; calls on the Commission and the Member States to expand and upgrade digital networks, especially in rural areas, and to support public-private investments in broadband and 5G/6G deployment, while maintaining cybersecurity standards and secure-by-design principles;

    38. Is convinced that, as digital connectivity infrastructure such as fibre, 5G and 6G will be crucial for future industrial competitiveness, the forthcoming MFF should include funds for the large-scale deployment of network infrastructure, bridging the existing deployment gap to achieve the 2030 Digital Decade targets, creating pan-European 5G coverage for citizens’ use and ensuring the successful deployment of Industry 4.0 tools;

    Fibre

    39. Stresses the importance of accelerating the deployment of fibre-optic networks and modern wireless communications systems that can deliver fast, secure and reliable digital services;

    40. Recognises that the need to prioritise direct fibre connections for homes, businesses and public institutions is crucial to ensure ultra-fast and reliable connectivity, in addition to network roll-outs with public works, such as roads, water and electricity, to streamline fibre roll-out;

    41. Welcomes the introduction of the Gigabit Infrastructure Act, which responds to the growing needs for faster, reliable and data-intensive connectivity; recognises the importance of the shared use of ducts and poles for deploying very high capacity networks to optimise resources and reduce costs; urges the Member States to streamline permitting processes and harmonise regulations to lower financial and administrative barriers to the expansion of fibre infrastructure;

    5G and 6G

    42. Believes that private investments are essential for deployment of electronic communication networks, 5G and 6G that are advanced enough in terms of transmission, speed, storage capacity, edge computing power and interoperability;

    43. Stresses that the enforcement and implementation of the Gigabit Infrastructure Act is further necessary for the creation of a one-stop shop for permits and a centralised digital permitting process to reduce delays in infrastructure deployment and to ensure uniform rules for infrastructure access, pricing and environmental impact assessments; calls, in this regard, for strong efforts in this area;

    44. Takes the view that the EU needs strong cybersecurity protection in all critical infrastructure sectors, with stricter measures to de-risk high-risk vendors in 5G and 6G networks, ensuring dense deployment of small cells and macro towers, particularly in urban and rural areas with inconsistent coverage, and ensuring the sustainability and energy efficiency of the infrastructure so as to support Europe’s global competitiveness in the digital economy;

    Spectrum

    45. Calls on the Commission and the Member States to work towards enhanced coordination of spectrum allocations, in particular through earlier identification and the harmonisation of the release of new frequencies, starting with 6 GHz frequencies; calls for a radio spectrum policy that promotes investment in Europe, including through the harmonisation of spectrum assignment policies across the Member States to accelerate 5G deployment based on best practices, the promotion of longer license durations and access to new spectrum such as the upper 6 GHz band in order to meet future demand and enable 6G; believes that a shared effort from public and private entities is necessary in order to increase the competitiveness of Europe and not lag behind the fastest growing networks in the world, i.e. in China and South Korea;

    Satellites and satellite communication systems

    46. Underlines the importance of satellite-based communications in developing EU digital infrastructure, increasing its resilience, strengthening the capabilities of EU actors, and reducing dependence on non-EU providers, particularly in the area of defence; highlights the need to provide alternative connectivity solutions for consumers in remote and rural areas;

    47. Highlights the strategic role of the EU space programme, as one of the pillars of EU sovereignty, in providing state-of-the-art and secure positioning, navigation and timing services for Galileo and EGNOS and cost-effective satellite communication services for GOVSATCOM; notes that this allows the EU and its Member States to have greater sovereignty in their satellite capabilities, including geopositioning, earth observation, space surveillance and connectivity; welcomes, in particular, the EU GOVSATCOM and IRIS2 programmes, which aim to ensure the short- and long-term availability of secure, reliable and cost-effective governmental satellite communication services for EU and national public authorities that manage critical security infrastructure and missions;

    48. Deplores the strong dependence on non-EU data for the tracking and surveillance of space objects; stresses the need for Europe to urgently reinforce its own capabilities and infrastructure in space situational awareness (SSA) to ensure open strategic autonomy and security; calls on the Commission and the Member States to significantly increase investment in EU-owned surveillance and tracking assets, and to develop effective mechanisms for information-sharing among the Member States, enabling Europe to independently monitor and protect its critical space infrastructure;

    49. Stresses the importance of private sector involvement in launcher technologies to further accelerate the deployment of IRIS2; stresses the importance of fostering a robust and competitive European space launch sector through greater private sector involvement and support for upstream and downstream industries; calls on the Commission to promote a European space industrial policy that strengthens sovereignty in space technologies and services by reducing strategic dependencies and improving the operational governance of European space programmes;

    50. Calls, to this end, for concrete measures to facilitate the provision of satellite services throughout Europe, including by defining common procedures and conditions; calls, in parallel, for fair competition, with clear and enforceable rules for all satellite constellations accessing the EU market;

    51. Notes that there are currently several issues with latency in satellite networks and recognises that the integration of satellite networks with 5G and, in the future, 6G technologies is pivotal in extending the reach and reliability of terrestrial networks;

    High-performance computing (HPC) systems

    52. Recognises the progress made in recent years in enhancing HPC; calls on the Commission to continuously integrate and enhance the computing power at EU HPC centres, in particular, enhancing the training of AI models and preparing for future advancements in supercomputing;

    53. Calls on the Commission to develop a coordinated strategy to bridge the gap between Europe’s cutting-edge HPC technology and its practical, scalable deployment across industries, including by creating a public network for supercomputing; notes that this strategy should foster collaboration between public institutions and private sector partners, including SMEs, to ensure that Europe’s HPC capabilities become a key driver of economic competitiveness and technological sovereignty;

    54. Highlights that HPC centres must ensure accessibility for developers and deployers of AI foundation models, generative AI and applied AI; notes that EuroHPC Centres should be available for these use cases and particularly for SMEs, start-ups and scale-ups; emphasises that this must be seamlessly complemented by initiatives to enable the development and deployment of AI in the EU;

    55. Welcomes the creation of new AI factories; underlines that AI factories will upgrade EuroHPC supercomputers to deliver computing capacity for AI and support start-ups and scale-ups in the training and large-scale development of general-purpose and trustworthy AI models;

    Hardware for computing: semiconductors, chips and quantum chips

    56. Believes that urgent action is needed to boost EU domestic semiconductor manufacturing, improving supply chain resilience by forming strategic global partnerships, encouraging start-ups and innovation, fostering cross-border collaboration in advanced semiconductor development and providing financial incentives, regulatory support and market access;

    57. Emphasises the need for legal certainty to support semiconductor development, ensuring secure supply chains for critical raw materials and avoiding disruptions caused by investment uncertainties;

    58. Urges to give utmost political importance to ensuring a sufficient supply of AI chips in the EU and to make it a focal point of EU digital industry policies; notes the increase in demand for AI chips driven by expanding applications in cloud computing, edge devices, autonomous systems and generative AI;

    59. Calls on the Commission to react to the new geopolitical realities and the use of digital supply chains as pressure tools; urges the Commission to find a negotiated solution to the US ban on the export of AI chips to 16 EU Member States;

    60. Calls on the Commission to put advanced AI chips, including their design and production, at the core of the revision of the Chips Act; calls on the Commission to present the revision this year, featuring a long-term strategy rooted in current geopolitical realities that builds European strategic indispensability through technological leadership, adequate production capabilities and a strong R&D ecosystem, which will be essential to secure European sovereignty in increasingly troubled times; believes that it is crucial to strengthen the interactions among research, training, suppliers and robust public infrastructure to accelerate the path from research, development, testing and finally full-load production;

    61. Believes that the EU should enhance its efforts on quantum chip development if it intends to accelerate the time-to-market for EU industrial innovation in quantum technology;

    62. Calls on the Commission to support the manufacturing within the EU of widely used chips e.g., for electronic devices and cars; calls for support for the development of chips that reduce the energy consumption of the digital sector;

    63. Underlines the need to support the performance of the circular economy and recalls that information and communications technology products and other electronics are part of the priority product groups in the working plan to be adopted by April 2025 under Regulation (EU) 2024/1781[24];

    64. Believes that additional funding under the forthcoming MFF must be allocated to the development of semiconductor production capacities and other next-generation semiconductor technologies and processes (e.g. photonic chips, wide-bandgap chips, as well as design, manufacturing, testing, assembly and advanced packaging) within the EU;

    Cloud services

    65. Recognises that there is a market need for sovereign solutions that offer enhanced levels of control over data for certain categories of sensitive data and acknowledges the risks associated with reliance on single dominant providers; calls for a strategy for reducing reliance on foreign cloud providers, while fostering European alternatives;

    66. Notes that the discussions on the EU Cybersecurity Certification Scheme for Cloud Services have not brought any results; points out that there are sovereignty considerations, in particular related to the extraterritoriality of binding legal regimes, that cannot be solved through technical discussions; calls on the Commission to propose a definition of sovereign cloud and its scope of application in the planned cloud and AI development act;

    67. Notes the need to secure data storage and computational power, and distributed computing infrastructure; calls on the Commission to ensure that cloud users have the ability to choose solutions that meet their needs by urgently removing barriers to switching and diversifying providers through multi-cloud strategies, and by fostering a competitive European cloud market, thereby reducing reliance on single providers and enhancing digital sovereignty;

    68. Calls on the Commission to leverage initiatives such as 8ra and IPCEI CIS to advance decentralised cloud and edge infrastructure, which are enablers of sovereignty and contribute to reducing reliance on foreign providers and ensuring resilience while enhancing operational flexibility within Europe;

    AI systems

    69. Welcomes the InvestAI initiative, including the AI gigafactories; emphasises the need for Europe to position itself as a global leader in AI model training, scientific research and quantum computing advancements; is committed to further supporting AI development by launching initiatives such as AI factories to provide computing power for start-ups, scale-ups and researchers;

    70. Calls on the Commission to further support the design and development of European AI and to adopt policies and measures that will enable European industrial sectors to benefit from their data and AI deployment;

    71. Emphasises that the delayed deployment of AI-driven innovations hinders technological progress, market competitiveness and digital transformation within the EU;

    72. Expects that the public-private financing model will unlock unprecedented private investment in AI that will open up access to supercomputers for start-ups and industry to supercomputers;

    Quantum

    73. Recognises the urgent need to define a clear roadmap for quantum technology development, including quantum computing and quantum encryption, ensuring that public and private investments lead to tangible commercial applications;

    74. Calls on the Commission to conduct an assessment of existing national quantum sandbox frameworks and how existing legislation applies to them in order to prevent market fragmentation; welcomes the announcement of the Quantum Strategy and Quantum Act in the Commission’s Competitiveness Compass;

    75. Urges the Commission to ensure that the Quantum Act, accompanied by an impact assessment, positions Europe as the leading region for quantum excellence and innovation by investing in R&D and innovation, mobilising funding to scale up the European quantum ecosystem, capabilities and production, and ensuring Europe’s leading quantum research is commercialised in Europe; underlines that it should deliver tangible technological applications by fostering policies that accelerate technological maturity and facilitate the transition from research to commercial success;

    76. Calls for targeted investments, industry collaboration and regulatory frameworks that support the development, scaling and market adoption of quantum technologies across key sectors;

    77. Calls for a coordinated EU strategy for post-quantum cryptography to protect data from future cyberthreats;

    Data centres

    78. Calls on the Commission to support ecosystems for sharing industry-specific data within industrial sectors, fostering collaboration and driving innovation, while maintaining data sovereignty and ensuring compliance with EU regulations, as outlined in the Data Act; urges the Commission for strong enforcement to ensure that dominant market players do not impose unfair terms on SMEs and mid-sized enterprises when accessing and sharing data;

    79. Believes that there is a need to ensure interconnected infrastructure that would allow data centres to work together efficiently under common standards with high-speed connectivity, while flexibility, security and scalability would be maintained; believes this interconnected system would help in ensuring distributed redundancy so that data and services remain available even in the event of a data centre failure;

    80. Calls on the Commission to prioritise interoperability across platforms, enabling the seamless integration of data across businesses and sectors, in alignment with the requirements of the Data Act, which mandate data portability and interoperability obligations for cloud and edge services; stresses the need for the robust enforcement of these provisions to prevent vendor lock-in and ensure that European industrial ecosystems can leverage data-driven innovation without technical or contractual barriers;

    81. Recalls the Commission’s plan to make data centres climate-neutral and highly energy efficient by 2030; sees the need to improve the integration of data centres with the energy system, focusing on heat reuse and providing flexibility services to the electricity grid needs; recognises the need to incentivise research for cooling and energy-efficient processors, while special attention should be given to supporting EU data centres; urges the Commission to ensure clear and consistent implementation of existing legal requirements for data centre operators across EU legislation and the Member States;

    82. Calls on the Commission and the Member States to increase and target public investment and to incentivise private investment in digital infrastructure to enable the growth and modernisation of data centres;

    Submarine cables

    83. Calls on the Commission to take coordinated action to protect submarine cables and reinforce cable security and repair capabilities; stresses the need for continued investment in the construction of new submarine cables to ensure redundancy; welcomes the EU’s role in co-financing such projects to enhance digital infrastructure and connectivity across the Member States; calls on the Commission to explore potential synergies between the maintenance of undersea digital and energy infrastructure;

    84. Emphasises the importance of improving EU and Member State repair capabilities and response mechanisms to handle submarine cable disruptions, which are essential for maintaining secure and uninterrupted communications; underlines the importance of international cooperation in repairing sabotaged cables and facilitating the necessary investments, and calls for the establishment of an EU-based rapid-response repair fleet to ensure swift recovery and operational continuity in the event of disruptions; calls on the Commission to carry out an assessment of regulatory measures to ensure fair access and security, regardless of whether the infrastructure is privately or publicly owned;

    85. Welcomes the adoption of the action plan on cable security, which will be organised around four pillars: prevention, detection, response and repair, and deterrence; highlights the importance of its full and timely implementation; urges, in the current geopolitical context, increased investment in technologies to strengthen the security and resilience of subsea and offshore infrastructure;

    86. Calls on the Commission to promote R&I to enable advanced technological innovations in cable security, including early warning systems and AI-driven threat assessments;

    87. Urges the Commission to review available instruments designed to better leverage private investments in support of Cable Projects of European Interest (CPEIs); calls on the Commission to include submarine cable projects in the list of IPCEIs; recognises the need to streamline and simplify the application and administrative process governing IPCEIs;

    Cybersecurity

    88. Recalls the legislative work carried out over the previous legislative term aimed at significantly improving cybersecurity in the EU; welcomes, in particular, the adoption of the Cyber Resilience Act, the Cyber Solidarity Act and the NIS2 Directive; stresses the need for the harmonised and timely implementation and enforcement of these measures;

    89. Calls on the Commission to present an evaluation report on the Cybersecurity Act and to propose a legislative act to review it in order to strengthen the EU’s cybersecurity framework, with a particular focus on the interplay between sovereignty and security; calls, furthermore, on the Commission to enhance the protection of strategic and critical infrastructure and prevent foreign interference from entities subject to extraterritorial legislation, as well as accelerating the adoption process for EU cybersecurity certification schemes; calls for ENISA’s mandate to be strengthened to coordinate crisis response, oversee cybersecurity certification for critical infrastructure and ensure uniform implementation of cybersecurity standards across the single market;

    90. Emphasises the importance of the upcoming European internal security strategy in strengthening cybersecurity and critical infrastructure protection;

    91. Notes with concern that, according to the second report on Member States’ progress in implementing the EU toolbox on 5G cybersecurity, 14 Member States have yet to implement any restrictions on high-risk suppliers, posing significant security vulnerabilities; calls for the full implementation of the EU toolbox for 5G security in order to reduce reliance on high-risk vendors; calls on the Commission to make the toolbox binding, specifically with regard to high-risk vendors in critical infrastructure;

    Simplification

    92. Notes that to achieve true technological sovereignty, the EU must have viable commercial alternatives; stresses that the EU must urgently pursue a comprehensive agenda of simplification and bureaucracy reduction to foster an innovation-friendly environment capable of supporting competitive European alternatives to dominant global digital players; underlines that excessive administrative burdens, fragmented regulatory frameworks, an incomplete digital single market and overly complex compliance procedures disproportionately impact European start-ups, scale-ups and SMEs, limiting their capacity to compete at global level; recognises that the EU should therefore prioritise regulatory streamlining and the deepening of the digital single market, ensuring that legislation is proportionate, innovation-driven and does not stifle the development of European technological solutions;

    93. Emphasises the need for new legislative proposals to be aligned with better regulation principles, ensuring that any new digital policy measure that affects competitiveness is accompanied by an impact assessment, including a competitiveness, SME and small mid-cap check that evaluates whether a given legislative instrument is necessary, proportionate and does not create unnecessary burdens for businesses, especially SMEs, and thus its effects on competitiveness, investment prospects and consumer welfare;

    94. Highlights that the simplification of EU legislation must not endanger any of the fundamental rights of citizens and businesses and thus jeopardise regulatory certainty; believes that any simplification proposal should not be rushed or proposed without proper consideration, consultation and an impact assessment;

    95. Welcomes the Commission’s commitment to fully implement the principle of burden reduction for companies in EU legislation; calls on the Commission, therefore, to enhance its efforts by aiming to remove more cost and administrative burdens for businesses compared to the benefits that would be derived from any new regulatory requirements introduced at EU level in the same policy area, so that barriers to market entry are removed to help European companies to scale and grow;

    96. Calls on the Commission to ensure consistent simplification, implementation and enforcement of EU digital legislation through the Digital Package, streamlining definitions and reporting procedures, assessing ways to alleviate reporting obligations and reducing the gap between industry and government;

    97. Believes that supporting companies and innovators to stay in Europe by developing the EU as an attractive and agile business environment is key to enhancing technological sovereignty; emphasises, in that regard, that excessive regulation and administrative burdens should be avoided and that EU rules should be clear, consistent, predictable, proportionate and technologically neutral, thus maintaining a globally competitive regulatory environment; believes that new public procurement methods and the development of regulatory sandboxes and test beds should also contribute to an innovation-friendly framework;

    98. Welcomes the Commission’s proposal of a 28th legal regime, recognising that a single, harmonised set of EU-wide rules will be a game changer for digital investment and innovation; believes that reducing regulatory fragmentation across 27 national legal regimes will boost private investment, lower compliance costs and accelerate the deployment of next-generation digital infrastructure, products and services; encourages the Commission to ensure that this framework specifically addresses regulatory barriers in the digital sector, such as permitting and cross-border data flows, in order to create a true digital single market;

    99. Urges the Commission to create a single point of contact to simplify the application process for private-sector access to EU funding mechanisms, ensuring that private companies, SMEs and start-ups can more easily participate in digital investment programmes;

    Energy

    100. Emphasises that data centres will put additional pressure on electricity grids, making it imperative to reinforce them through anticipatory investments; stresses that data centres can also help stabilise the grid by participating in demand-side flexibility; calls for measures to incentivise such contributions based on the implementation of the revision of the European electricity market reform;

    101. Calls on the Commission and the Member States to propose and implement instruments that ensure orderly planning of the escalating energy demand from data centres, facilitating their strategic placement near available energy sources and thus minimising reliance on the broader grid infrastructure;

    102. Recognises that fibre is more energy efficient than traditional copper networks; acknowledges the importance of reducing energy consumption in data transmission and ensuring long-term stability and efficiency;

    103. Calls on the Commission to ensure a reliable and sufficient clean energy and net-zero technology supply to support the digital infrastructure of the future;

    Skills

    104. Recognises the urgent need for more skilled professionals in digital fields to meet the EU’s strategic objectives; calls on the Member States to develop national strategies and incentives to retain European talent and attract the world’s best digital professionals, thereby strengthening the EU’s innovation capacity and technological leadership;

    105. Stresses the importance of closing the digital and STEM skills gap to enhance technological resilience, innovation capacity and open strategic autonomy; calls on the Member States to strengthen investments in digital education, upskilling and reskilling, particularly in areas essential for the green and digital transitions; supports prioritising investments that address digital skills shortages, particularly in AI, cybersecurity, data analysis and clean technologies, in order to support innovation and technological sovereignty;

    106. Calls for coordinated strategies at national level to improve access to high-quality STEM education, promote lifelong learning and attract talent to ICT and related fields; encourages partnerships between public institutions, industry and educational providers to ensure alignment between curricula and evolving market needs;

    107. Calls for intensified efforts to improve digital literacy and skills across all demographics, focusing on early STEM education, vocational education and training, and lifelong learning in digital technologies; recommends aligning national education and training strategies with the EU Digital Decade goal of 80 % of the population possessing basic digital skills by 2030, with a focus on gender-inclusive policies to increase women’s participation in ICT and STEM fields; calls on the EU institutions to take concrete steps to uphold the commitments referred to in the European Declaration on Digital Rights and Principles for the Digital Decade, both within the EU framework as in the Union’s cooperation with third countries;

    108. Supports the establishment of a common EU certification framework for digital and technical skills to improve the recognition and portability of qualifications among the Member States;

    109. Encourages the European Investment Bank and national development institutions to support digital talent retention by co-investing in European deep-tech start-ups, ensuring that EU-funded innovation remains within the region and contributes to Europe’s technological sovereignty;

    Research and innovation

    110. Recognises the importance of bridging the gap between research and commercialisation and calls on the Commission to enhance the valorisation of innovation within the EU;

    111. Believes that Europe’s ability to transform research into market-ready solutions is critical for building necessary capabilities and reducing reliance on non-EU technologies;

    112. Emphasises that funding needs to be strategically allocated to accelerate the development and market introduction of solutions that strengthen Europe’s technological resilience and drive innovation; underlines the importance of a more agile, excellence-based funding structure, particularly in improving the translation of research into industrial applications; calls for increased investment in R&I to strengthen Europe’s knowledge and technological capabilities and insists that EU research, development and innovation (RDI) funding be based on open competition and excellence;

    113. Highlights the need for policies that support industrial innovation, including targeted investment in key strategic technologies where Europe can lead globally, such as quantum computing, in order to build an innovation ecosystem;

    114. Believes that private investment in RDI is of utmost importance and calls for the EU to create incentives that effectively leverage private funding for the development of critical technologies, including through public-private partnerships;

    115. Stresses the urgent need for stronger incentives to mobilise private sector capital for technology-driven innovation; encourages the Member States to introduce targeted fiscal incentives, regulatory simplification and risk-sharing instruments designed to attract private equity to the technology and digital sectors; highlights the need to streamline cross-border capital flows within the single market to facilitate access to finance for innovative European start-ups;

    Standards

    116. Strongly believes that promoting interoperability and EU standards is paramount to fostering competitiveness in the technology sector, as it ensures that products can be connected and work with each other, thus fostering innovation and open markets; recalls that both interoperability and common technological standards pave the way for the functioning of the single market;

    117. Underlines that the Commission must increase its engagement in existing global standardisation structures and focus on the international uptake of European standards through a bottom-up approach, avoiding centralisation;

    Partnerships

    118. Welcomes the EU’s commitment to negotiating DTAs that facilitate secure and competitive digital infrastructure development with partner countries; encourages the Commission to increase efforts in negotiating DTAs with additional partner countries;

    119. Calls on the Commission to accelerate technical cooperation in multilateral forums such as the G7, the Organisation for Economic Co-operation and Development and the World Trade Organization (WTO) so as to develop global standards for digital governance, AI regulation, cross-border data flows and emerging technologies;

    120. Urges the Commission to advance negotiations on a permanent solution to the WTO moratorium on e-commerce to prevent the introduction of digital tariffs, ensuring international digital trade remains open, predictable and conducive to innovation;

    °

    ° °

    121. Instructs its President to forward this resolution to the Council and the Commission.

    MIL OSI Europe News –

  • MIL-OSI Asia-Pac: Cluster of Candida auris cases found in Kowloon Hospital

    Source: Hong Kong Government special administrative region

    The following is issued on behalf of the Hospital Authority:

    The spokesperson for Kowloon Hospital (KH) made the following announcement today (June 25):

    A 77-year-old female patient in a rehabilitation and extended care ward was confirmed to be carrying Candida auris on June 12 without signs of infection. In accordance with the prevailing infection control guidelines, the hospital commenced a contact tracing investigation. Four more female patients (aged 85 to 99) from the same ward were subsequently confirmed to be carrying Candida auris without signs of infection. Among the five patients, two patients have been discharged. One patient is in critical condition due to her underlying disease. The remaining two patients are now being treated in isolation at KH and are in stable condition.

    The ward concerned has adopted the following enhanced infection control measures:
     

    1. Enhanced patient and environmental screening procedures;
    2. Applied stringent contact precautions and enhanced hand hygiene of staff and patients; and
    3. Thorough cleaning and disinfection of the ward concerned.

    The hospital will continue the enhanced infection control measures and closely monitor the situation in the ward. The cases have been reported to the Hospital Authority Head Office and the Centre for Health Protection for necessary follow-up.

    MIL OSI Asia Pacific News –

  • MIL-OSI USA: Harshbarger, Sherrill Reintroduce Bipartisan Legislation to Digitize Prescription Information, Improve Patient Safety

    Source: United States House of Representatives – Representative Diana Harshbarger (R-TN)

    WASHINGTON, D.C. – Today, U.S. Representative Diana Harshbarger (R-TN), a practicing pharmacist before being elected to Congress, and U.S. Representative Mikie Sherrill (D-NJ) reintroduced the bipartisan Prescription Information Modernization Act. This legislation would allow the Food and Drug Administration (FDA) to move forward with a proposed rule allowing drug manufacturers to transmit prescribing information electronically to doctors and pharmacists, as opposed to printed copy, as currently required.

    “Pharmacists and physicians deserve timely, accurate data when making decisions that impact patient health, not pages of printed material that often arrive late and are immediately discarded,” said Rep. Harshbarger. “This bipartisan bill is a practical update that empowers healthcare professionals with real-time digital access, cuts waste, and ensures patients are receiving the most up-to-date information. Thank you to my colleague, Representative Sherrill for working with me to bring prescribing information into the 21st century.”

    “I’m focused on improving our healthcare system to ensure healthcare providers are able to provide the best possible care to patients. Under outdated rules, providers are prohibited from receiving prescribing information for medications digitally. This legislation would finally modernize our system, allowing pharmacists to access real-time updates on prescription medications that will ensure they can dispense medicines to patients safely while reducing waste at the same time.” said Rep. Sherrill.

    Under the current policy, which has not been updated since 1962, prescribing information sent to providers that contain important information related to a specific drug must be printed, running an average of 45 pages per prescription. This information is not intended for patients but rather contains the drug’s chemical makeup and information that informs a healthcare professional on the drug’s interaction with other drugs. In 2014, the FDA proposed a rule that would allow the electronic distribution of prescribing information. Since then, Congress has used the appropriations process to prevent the agency from finalizing that rule, requiring the bulky paper labels to be printed and distributed, even though many are immediately discarded by healthcare professionals for being outdated.

    The Harshbarger-Sherrill legislation would give healthcare professionals the option to choose how they receive prescribing information. In most cases, healthcare professionals choose to receive the information digitally because the information is available in real-time. Printed information takes approximately 8-12 months from printing to shipment, and information is often outdated by the time it reaches the recipient.

    This legislation has drawn support from leading pharmacy and healthcare advocacy organizations, including the Alliance to Modernize Prescribing Information (AMPI) and the following groups: Academy of Managed Care Pharmacy (AMCP), Allergy & Asthma Network, American Pharmacists Association, AmGen, Asthma and Allergy Foundation of America, Association for Accessible Medicines, Beyond Type 1, Biotechnology Innovation Organization, BioNJ, BioUtah, Boomer Esiason Foundation, Environmental Paper Network, Georgia Bio, Healthcare Distribution Alliance, HealthCare Institute of New Jersey, LUNGevity Foundation, Lupin, Maryland Tech Council, MassBio, McKesson, National Association of Chain Drug Stores, National Consumers League, National Grange, NewYorkBIO, North Carolina Biosciences Organization, Texas Healthcare and Biosciences Institute, and Zero Cancer.

    Additional sponsors of this legislation include Reps. David Valadao (R-CA), Don Davis (D-NC), Ken Calvert (R-CA), Scott Peters (D-CA), Julia Letlow (R-LA), Deborah Ross (D-NC), Brad Schneider (D-IL), Steve Womack (R-AR), and Paul Tonko (D-NY).

    You can read the full bill text HERE.

    MIL OSI USA News –

  • MIL-OSI USA: Griffith Announces $1.29 Million HHS Grant to STEP Inc.

    Source: United States House of Representatives – Congressman Morgan Griffith (R-VA)

    The U.S. Department of Health and Human Services (HHS) has awarded STEP Inc., located in Franklin County, Virginia, a $1,296,059 grant. The funding supports head start and early head start projects. U.S. Congressman Morgan Griffith (R-VA) issued the following statement:

    “Solutions that Empower People (STEP) serves communities in Franklin and Patrick Counties. 

    “This grant for nearly $1.3 million helps STEP support its head start and early head start programs.”

    BACKGROUND

    According to its website, Solutions That Empower People (STEP), Inc. is a dynamic community action agency that provides services at significant milestones throughout life. Programs are designed to partner with individuals and families to help them overcome adversity and enhance their quality of life through community, economic, personal, and family development.

    In a recent Health Subcommittee hearing with Congressman Griffith present, Secretary Kennedy noted President Trump’s Budget request recommends Head Start continue to receive funding equal to the FY 2025 enacted level.

    ###

    MIL OSI USA News –

  • MIL-OSI USA: Reps. Allen and McBath Lead Effort to Increase Access to Care for Energy Workers

    Source: United States House of Representatives – Congressman Rick Allen (R-GA-12)

    Today, Congressman Rick W. Allen (GA-12), Chairman of the Subcommittee on Health, Employment, Labor, and Pensions (HELP), and Congresswoman Lucy McBath (GA-06), introduced the Health Care for Energy Workers Act to increase access to care for current and former energy workers.

    Specifically, this bipartisan, bicameral legislation would update the Energy Employees Occupational Illness Compensation Program Act (EEOICPA) to allow nurse practitioners (NPs) and physician assistants (PAs) to order care for current and former Department of Energy (DOE) workers who receive health care under this Department of Labor (DOL) program. The EEOICPA provides compensation and medical benefits to employees who work or have worked in the nuclear weapons industry. Under current EEOICPA regulations, NPs and PAs are unable to order home health care services for patients, creating unnecessary barriers to care, especially for patients in rural communities.

    Upon introducing the bill, Congressman Allen issued the following statement:

    “Georgia’s 12th District is home to thousands of energy workers employed at Plant Vogtle and the Savannah River Site, many of whom qualify under the EEOICPA for their health care needs. However, those who live in rural areas are often hours away from the nearest physician, highlighting the need for greater flexibility to ensure these beneficiaries receive the care they deserve. I am proud to lead this bill with Congresswoman McBath to cut unnecessary red tape and improve access to care for energy workers in Georgia and nationwide,” said Congressman Allen.

    “America’s workers deserve access to the health care that will help them lead full lives,” said Rep. McBath. “Too often, necessary treatments might not be available in rural communities. This bill represents an important next step in ensuring more frontline workers have access to quality and efficient care as they serve our communities.”

    NOTE: The Health Care for Energy Workers Act would benefit over 7,000 Georgia energy workers, including many employed at Plant Vogtle and the Savannah River Site. A Senate companion bill has been introduced by U.S. Senators Marsha Blackburn (R-TN), John Hickenlooper (D-CO), and Patty Murray (D-WA).

    MIL OSI USA News –

  • MIL-OSI United Kingdom: UK partners with Gavi to help save up to eight million lives by 2030

    Source: United Kingdom – Executive Government & Departments 3

    Press release

    UK partners with Gavi to help save up to eight million lives by 2030

    New UK support will see millions of children vaccinated against some of the world’s deadliest diseases, Foreign Secretary David Lammy announced today at Gavi’s global summit in Brussels.

    • The UK will support Gavi as a leading investor in the Vaccine Alliance, committing £1.25 billion to vaccinate millions of children between 2026-2030.
    • The commitment will help Gavi protect up to 500 million children from some of the world’s deadliest diseases like meningitis, cholera and measles.
    • Gavi’s global vaccination work prevents the spread of dangerous infectious diseases while boosting investment and jobs in UK science as part of the Government’s Plan for Change.

    New UK support will see millions of children vaccinated against some of the world’s deadliest diseases, Foreign Secretary David Lammy announced today at Gavi’s global summit in Brussels.

    The UK’s new £1.25 billion pledge to Gavi, the Vaccine Alliance, extends a close 25-year partnership which has helped to vaccinate over one billion children globally against diseases like meningitis, to prevent more than 18 million lives being lost, and to improve countries economic prospects. Since 2000, when the UK was a founding member, Gavi has generated $250 billion in economic benefits through reduced death and disability. Gavi now receives investment from 56 countries and over 60 organisations. 19 countries have graduated from Gavi support, including India and Indonesia who have now become donors to Gavi.

    Today’s pledge will help Gavi in their mission to protect up to 500 million children between 2026-2030 and save up to eight million more lives.

    It will also have a positive impact at home, creating British jobs and growth, through partnerships with health companies like GSK, which employs about 14,000 people in the UK, as the government delivers on its Plan for Change to boost economic growth.

    Gavi helps strengthen the UK’s health security by preventing the spread of dangerous infectious diseases before they reach our borders. This reduces pressures on our hospitals and health workers, enabling an NHS fit for the future.

    UK Foreign Secretary, David Lammy said:

    Gavi’s global impact is undeniable. Over 1 billion children vaccinated, over 18 million lives saved, over $250 billion injected into the global economy.

    I’m immensely proud of the role the UK has played in reaching these milestones. Our ongoing partnership with Gavi will give millions of children a better start, save lives and protect us all from the spread of deadly diseases.

    GSK is a leading supplier to Gavi, providing vaccines for diseases like malaria and human papillomavirus (HPV). Their partnership supports UK research, science and innovation.

    Earlier this week, Minister for Development Baroness Chapman visited GSK’s research campus in Stevenage, alongside the Gavi CEO, Dr Sania Nishtar and and GSK’s President of Global Health, Deborah Waterhouse. Together they discussed some of the world-leading research being conducted by British scientists, including on new malaria and TB vaccines.

    UK Minister for Development, Jenny Chapman said:

    Our modern approach to development means focussing on where we can have the biggest impact, and on areas the UK can lead. We must ensure every pound delivers for the UK taxpayer and the people we support.

    Our partnership with Gavi does just that. It will save the lives of millions of children around the world, to grow up safe from deadly diseases like cholera and measles. And it will make the world and the UK healthier and safer, helping prevent future pandemics.

    It is partnership based on the UK’s world-leading expertise, not just money. By rolling out vaccines developed by British scientists, Gavi puts our best brains and their innovations on the world stage, and supports UK jobs and growth.

    CEO of Gavi, the Vaccine Alliance, Dr Sania Nishtar said:

    The United Kingdom is one of Gavi’s longest and most committed partners. This pledge for our next strategic period reaffirms its status as a leader in global health and I am delighted that we will be able to count on its support in our next strategic period, working together and leveraging some of the best in British science and innovation as we save lives and fight outbreaks around the world.

    President Global Health at GSK, Deborah Waterhouse said:

    The UK’s world-class infectious disease research continues to inform our work at GSK and combined with our scientific expertise, is enabling GSK to advance malaria prevention and control, directly impacting global health agendas and access strategies.

    As a longstanding partner of Gavi, the Vaccine Alliance – an organisation that plays a vital role in delivering vaccines to children in lower-income countries – we welcome the UK Government’s new pledge to Gavi, to help save up to eight million lives by 2030 and get ahead of disease together.

    Media enquiries

    Email newsdesk@fcdo.gov.uk

    Telephone 020 7008 3100

    Email the FCDO Newsdesk (monitored 24 hours a day) in the first instance, and we will respond as soon as possible.

    Updates to this page

    Published 25 June 2025

    MIL OSI United Kingdom –

  • MIL-OSI Canada: Doctor Recruitment Partnership Announcement

    Source: Government of Canada regional news

    L-R: Nick Hilton, MLA for Yarmouth and Ministerial Assistant for Health and Wellness; Dr. Mohammad Srour; Michelle Thompson, Minister of Health and Wellness; Premier Tim Houston; Wadih Fares, Honorary Consul of Lebanon in Halifax; and Dr. Gus Grant, CEO and Registrar of the College of Physicians and Surgeons of Nova Scotia, at the announcement. (Province of Nova Scotia)

    MIL OSI Canada News –

  • MIL-OSI Africa: Strengthening Communication for Better Food Safety in Senegal

    The Food and Agriculture Organization of the United Nations (FAO), in collaboration with the Association of Journalists in Health, Population and Development (AJSPD), organized a five‑day capacity‑building workshop in Thiès (June 16–20, 2025) to train Senegalese media professionals on food safety issues. The training aimed to deepen their understanding of the key challenges, legal frameworks, technical tools, and best practices related to food safety.

    In her opening remarks, Mrs Bintia Stephen‑Tchicaya, FAO’s Acting Sub‑Regional Coordinator for West Africa, complimented AJSPD for its outstanding work in health and development journalism. “You are essential actors in building a culture of prevention and responsibility around food safety. Through your investigations, reports, and columns, you can shift mindsets, influence behaviors, and hold decision makers to account. We count on your renewed commitment to consistently include food safety in your reporting,” she said.

    Food safety remains a major challenge across Africa. According to a 2015 WHO estimation, more than 91 million people in Africa fall ill annually from foodborne illnesses, resulting in around 137 000 deaths. These alarming figures highlight the urgent need to raise public awareness and influence policymakers, professionals, and consumers alike.

    Professor Amadou Diop, Chair of the National Codex Committee in Senegal, reminded participants that the Codex Alimentarius – fully endorsed by Senegal – sets rigorous, science‑based international food safety standards. “These standards only have impact,” he said, “if they are understood, communicated, and applied – especially by media professionals. Journalists are not only messengers but educators, preventers, and mobilizers who can translate complex scientific data into accessible, actionable messages.”

    The workshop featured theoretical lectures, panel discussions, case studies, and practical field work. Journalists visited Thiès’s main transport hub to assess street food safety issues firsthand. Captain Armand Seck of the Thiès hygiene brigade reported numerous violations: cramped stalls, poor ventilation, inadequate lighting, and makeshift food stands under tarpaulins.

    Recognizing the lack of formal training among journalists on food safety, the program covered legal frameworks, international standards like Codex, microbiological, physical, and chemical hazards, surveillance systems, and safe handling practices for food preparation and sale.

    Participants proposed several recommendations to improve communication, awareness, and advocacy: fostering stronger collaboration between media, health authorities, and partners; organizing regular specialized training; publicizing safe food-handling practices; educating policymakers including parliamentarians; and creating regional professional networks.

    This workshop marks an important milestone in promoting quality information on food safety to benefit consumers in Senegal and across West Africa. It is part of the project “Strengthening capacity to respond to food safety emergencies and improving street food quality in Burkina Faso, Mali, and Senegal,” funded by the Grand Duchy of Luxembourg, with the goal of enhancing emergency response to food safety threats and improving street food hygiene standards in West Africa.

    Distributed by APO Group on behalf of Food and Agriculture Organization of the United Nations (FAO): Regional Office for Africa.

    MIL OSI Africa –

  • MIL-OSI Africa: Eritrea: Training of Trainers to Control Hepatitis B Virus Infection


    Download logo

    The Ministry of Health has organized a training of trainers program to introduce a vaccination initiative aimed at controlling Hepatitis B, a virus that causes liver inflammation and is transmitted vertically from mother to child. Representatives from regional health branches, vaccination program heads, and partners are participating in the training.

    Mr. Tedros Yihdego, Head of the National Vaccination Program at the Ministry of Health, stated that the objective of the training is to enhance understanding of the vaccination program, which is set to begin on 1 August and will administer the vaccine within the first 24 hours of birth.

    Dr. Nonso Ejiofor, WHO Representative in Eritrea, and Dr. Nande Putta, Chief of Child Survival and Development at UNICEF, noted that in Eritrea due to the equal implementation of the vaccination program in both urban and rural areas, the rates of infection and death have significantly declined. They expressed full support for the program.

    Mr. Tedros also expressed confidence that the national program will be successfully implemented through the coordinated participation of all relevant institutions.

    Distributed by APO Group on behalf of Ministry of Information, Eritrea.

    MIL OSI Africa –

  • MIL-OSI Canada: Government of Canada celebrates AI and Tech Innovation in Toronto

    Source: Government of Canada News (2)

    Minister Solomon meets with leaders in innovation during Toronto Tech Week

    June 25, 2025 – Toronto, Ontario 

    Today, the Honourable Evan Solomon, Minister of Artificial Intelligence and Digital Innovation and Minister responsible for the Federal Economic Development Agency for Southern Ontario (FedDev Ontario), attended Frontiers of AI, co-hosted by MaRS Discovery District (MaRS), Vector Institute (Vector) and the University of Toronto, to discuss the future of Canada’s AI economy.  

    Minister Solomon began the day at MaRS, a leading innovation hub supporting science and technology startups and scaleups, where he highlighted Canada’s leadership in AI development. He reiterated the Government of Canada’s commitment to working alongside innovators to drive growth, create jobs, and scale Canada’s AI industry at home and on the world stage.

    Minister Solomon also met with a number of businesses, including FedDev Ontario-supported Ecopia AI (Ecopia), a Canadian technology company using AI to create high-precision mapping data for critical applications around the world.

    Vector’s world-class research community is pushing the boundaries of AI science, from accelerating equitable access to liver transplants to improving cancer care, and through its secure health AI network, is enabling data-driven solutions to critical issues like staffing shortages, wait times, and patient outcomes. This afternoon, Minister Solomon announced an investment of $3.5 million for Vector to deliver HealthSpark – an initiative to fast-track AI innovation in Canadian health care and services. With this support, high-potential scaleups and startups will receive training, mentorship and access to key networks and AI engineering expertise, as they develop AI solutions to tackle some of our most pressing healthcare challenges.

    The Government of Canada is making strategic investments to support AI adoption to foster real solutions, improve lives, reshape industries and reimagine what is possible.

    MIL OSI Canada News –

  • MIL-OSI USA: California awards $15 million to support economic growth in tribal communities across the state

    Source: US State of California Governor

    Jun 25, 2025

    What you need to know: As part of California Jobs First, the state is awarding $15 million through the Regional Investment Initiative to support California Native American tribal partners in creating jobs and developing high-paying and fulfilling careers.

    Sacramento, California – Today, Governor Newsom and the California Jobs First Council announced $15 million in grants to 14 California Native American tribes, tribal coalitions, and tribally led organizations. The grants support projects aimed at spurring economic growth, providing job training, cultivating business development, protecting the environment, and conducting research and development.

    This $15 million commitment recognizes that, since time immemorial, California tribes have been best aware of the opportunities and advantages of their regions and communities. California is proud to partner with tribes across the state to support good jobs and expand economic opportunity in a meaningful and lasting way, delivering on the promises we made years ago.

    Governor Gavin Newsom

    “Our tribal partners are uniquely positioned to grow their local communities and economies utilizing cultural values and principles of self-determination,” said Tribal Affairs Secretary Christina Snider-Ashtari. “Today’s awards promise to advance our shared goals for a stronger economy and greater opportunities for all Californians.” 

    Today’s announcement includes awards for projects spanning a range of local investments, from developing community centers to constructing a bioenergy production facility:

    • Berry Creek Rancheria of Maidu Indians was awarded $1.51 million to develop a strategic energy plan.

    • California Indian Museum and Cultural Center was awarded $587,000, and will develop a career pathway program in the health sector titled “Climate-Ready Tribal Community Health Representatives.”

    • Kashia Band of Pomo Indians were awarded $999,000 in order to conduct the pre-development activities necessary to establish the Kashia Aquaculture Center.

    • Mechoopda Indian Tribe of Chico Rancheria was awarded $999,000, to conduct the pre-development activities necessary to establish a Resilience Hub and Multi-Functional Community Center.

    • Native Development Network was awarded $776,000 to conduct research supporting the development of career pathways in the clean economy, healthcare, and high-tech sectors.

    • Native First Lending was awarded $1 million to develop a revolving loan fund for Native American businesses in Los Angeles County.

    • Nevada City Rancheria Nisenan Tribe was awarded $744,000 to support land restoration activities on two culturally significant historical sites.

    • Owens Valley Career Development Center was awarded $1.995 million to develop career pathways in the clean economy.

    • Pit River Tribe was awarded $954,000 for a comprehensive land use assessment to identify locations for new businesses in industries such as tourism and outdoor recreation.

    • Scotts Valley Energy Corporation was awarded $1 million for a bioenergy production facility.

    • Southern California Tribal Chairperson’s Association was awarded $933,000 to develop an Innovation Ecosystem to support small businesses in the clean economy sector.

    • Table Mountain Rancheria was awarded $950,000 to conduct pre-development activities for the TMR Healthcare Center.

    • The Sierra Fund was awarded $945,000, which will provide economic and workforce development planning support for two local Tribes.

    • Tule River Economic Development Corporation was awarded $1.6 million to develop career pathways and provide training in the clean economy sector.

    “Each of these awards represents our efforts to invest in locally driven projects that will advance meaningful job creation, attraction, and access across California,” said Dee Dee Myers, Senior Advisor to Governor Newsom and Director of GO-Biz and Stewart Knox, Secretary of Labor & Workforce Development. “The California Jobs First Council is honored to have the opportunity to invest in these 14 communities, and we look forward to working closely with our tribal nation partners to ensure the ongoing success of their projects.”

    See full award details here. 

    California Jobs First

    In February, Governor Newsom released the California Jobs First Economic Blueprint — a new economic vision for California’s future. The Blueprint outlines key initiatives to support regional growth throughout the state, invest in job training for the future, attract job creators, and strengthen California’s innovation economy — all to help increase access to good-paying jobs for Californians. 

    As part of California Jobs First, the state has invested $287 million since 2022 to develop viable projects that advance strategic sectors in regional economies.

    California is the fourth-largest economy in the world. With an increasing state population and recent record-high tourism spending, California is the nation’s top state for new business starts, access to venture capital funding, and manufacturing, high-tech, and agriculture.

    Recent news

    Jun 25, 2025

    News What you need to know: The First Partner launched her annual Book Club today, which features great kids’ reads curated by librarians across California, as well as investments to support library community programming. SACRAMENTO – California First Partner Jennifer…

    Jun 25, 2025

    News What you need to know: Today marked the start of the final phase of work on the Wallis Annenberg Wildlife Crossing – a monumental wildlife preservation effort in Southern California. LOS ANGELES – Governor Gavin Newsom announced today that the final phase of the…

    Jun 25, 2025

    News What you need to know: President Trump’s unlawful deployment of military personnel to Los Angeles has slashed California’s National Guard fentanyl and drug interdiction force by 32% — undermining public safety and weakening border fentanyl seizure operations….

    MIL OSI USA News –

  • MIL-OSI USA: Congressman Nick Langworthy Announces Over $2.6 Million Grant for Head Start Projects in Allegany County

    Source: US Congressman Nick Langworthy (NY-23)

    WASHINGTON, D.C. – Today, Congressman Nick Langworthy (NY-23) announced that Allegany County Community Opportunities and Rural Development has been awarded $2,698,394 by the U.S. Department of Health and Human Services (HHS) for Head Start Projects.  

    “I am proud to support the over $2.6 million from HHS for Head Start projects in Allegany,” said Congressman Langworthy. “Head Start programming is essential to families in our community and this funding will ensure children have the best opportunity to learn and be nurtured. I am excited to see this program in Allegany flourish with this federal assistance.”

    Head Start is based on the premise that all children share certain needs and that children of income eligible families can benefit from a comprehensive developmental program to meet those needs. The program maximizes the strengths and unique experiences of each child. The family, which is the principal influence on the child’s development, is a direct participant in the program.

     

    ###

    MIL OSI USA News –

  • MIL-OSI United Kingdom: NHS App overhaul will break down barriers to healthcare and reduce inequalities

    Source: United Kingdom – Government Statements

    Press release

    NHS App overhaul will break down barriers to healthcare and reduce inequalities

    The NHS App will be transformed so it gives every patient information, choice and control of their own healthcare.

    • Upgraded NHS App will help tackle nation’s health inequalities and give patients access to the best care
    • New tool will give everyone choice based on patient satisfaction, waiting times and healthcare outcomes
    • Healthcare democratised through new tool, with information about conditions and procedures at the touch of a button

    The NHS App will be transformed so it gives every patient – whatever their postcode or background – information, choice, and control of their own healthcare so they have the best information at their fingertips, as the government’s 10 Year Health Plan closes the stark health inequalities faced by millions of people.

    Under the current system, wealthier patients often have more information about the country’s hospitals and access to better care. The improved NHS App will democratise care, so everyone, including those from working class communities, has the information they need about their conditions or procedures they’re due to go through.

    Using AI, the new My Companion tool will give patients direct access to trusted health information, so there are always 2 experts in every consulting room – the clinician and the patient. It will help patients articulate their health needs and preferences confidently – providing information about a health condition if they have one, or a procedure if they need one. It will support patients to ask questions, including any they may have forgotten about or felt too embarrassed to raise at an in-person appointment.

    A new feature called My Choices will help people find everything from their nearest pharmacy, to the best rated providers for heart, hip or knee surgery – all on the app. It will provide a range of data on providers across the country – such as which delivers the shortest waits, has the best patient outcomes, the best patient satisfaction scores, or is simply closest to home – so anyone, anywhere, can pick care based on their own preferences. People who just want to be sent to their local provider will be as a default.

    This will end the ‘one size fits all’ approach, which often misses the distinct needs of different people, including women, people from ethnic minority backgrounds or people who live in more rural communities, among many others.

    It comes as the Health Secretary today unveiled a radical package of measures under the 10 Year Health Plan to tackle health inequalities, freeing up billions of pounds to move critical resources like medicines and equipment to the communities that most need them, alongside changes to the way GP funding is distributed to help working class communities and coastal areas.

    Speaking in Blackpool today, Health and Social Care Secretary, Wes Streeting, said:

    The NHS feels increasingly slow and outdated to the generation that organises their lives at the touch of a button. If you get annoyed at Deliveroo not getting your dinner to you in less than an hour, how will you feel being told to wait a year for a knee operation? A failure to modernise risks this generation walking away from the NHS, first for their healthcare, and then with their taxes.

    People won’t accept paying higher and higher taxes to fund a health service that no longer meets their needs. And the lack of control people feel over their own lives is made worse by an analogue, ‘computer says no’, NHS. We can only close this inequality and shut down this risk to the NHS’s future, through a revolution in patient power.

    The ambition of our 10 Year Health Plan is nothing less than to provide NHS patients with the same ease and convenience that’s afforded to private patients. The good news is that technology gives us the opportunity to democratise healthcare in a way never before possible. It can empower patients with choice and control and make managing our healthcare as convenient as doing our shopping or banking online.

    Technology can be the great leveller. Look at what Martin Lewis, the Money Saving Expert, has done for personal finances. For ordinary people – who could never afford their own financial adviser – it is simple and easy to make your hard-earned money go further. Our 10 year plan for health will do the same for NHS patients – giving them easy access to information, to help them improve their health.

    Dr Vin Diwakar, NHS National Director of Transformation, said:

    The shift from analogue to digital set out in the 10 Year Health Plan will transform the services we offer through the NHS App, making it the single most important tool patients use to get health information and control their care.

    These exciting reforms will be invaluable in combating health disparities and providing world-leading access to those who have not previously been able to get care on their own terms – by providing transparent data about services or supporting carers to manage the care of loved ones. We will co-design these with patients and carers to ensure that the app can be accessed by everyone.

    All this and more will be available from your pocket, making controlling your own healthcare as easy as placing an online shopping order.

    The government has already exceeded its target to increase the number of hospitals allowing patients to view appointment information on the NHS App up to 85% by the end of March 2025. This has now reached 87%, up from 68% in July 2024. It means millions of patients are already starting to benefit from greater choice and flexibility in the way they access healthcare.

    Since July 2024, these features have saved almost 5.7 million hours of staff time, including 1.26 million clinical hours across health settings – together with the 1.5 million missed appointments avoided, the shift to the NHS App has helped save the equivalent of £622 million.

    The Health and Social Care Secretary also announced today that people from traditionally working-class communities, unpaid carers and over 50s will be among those supported onto the NHS career ladder, as the government’s Plan for Change tackles rampant health inequalities and gets Britain working. The government has confirmed a new pilot to recruit an initial 1,000 people from groups or areas worst hit by unemployment.

    Backed by £5 million, the new recruitment scheme will target those who historically face barriers into employment, including young people not in education or training, unpaid carers, care leavers, people with special educational needs and disabilities, people with long-term health conditions or disabilities, ethnic minority groups with no/low level qualifications, refugees, asylum seekers and prison leavers.

    Covering communities across the country, the programme may teach important skills to support a move into the health and care sector, alongside support with job applications and preparing for interviews. Participants will also have the opportunity to undertake a work placement in a local health and care employer.

    Many will then move onto important roles, such as health support workers, facilities management, administrative positions, nursing support roles and pharmacy support roles, kickstarting an exciting, long-term career within health and care.

    Through our Plan for Change, this government is committed to raising living standards, driving growth and productivity, and tackling inequalities.

    Updates to this page

    Published 25 June 2025

    MIL OSI United Kingdom –

  • MIL-OSI Security: Record 769 arrests and USD 65 million in illicit pharmaceuticals seized in global bust

    Source: Interpol (news and events)

    25 June 2025

    Operation reveals growing demand for semaglutides and peptides as ‘lifestyle enhancers’

    SINGAPORE – An INTERPOL-coordinated operation across 90 countries has resulted in the seizure of 50.4 million doses of illicit pharmaceuticals worth USD 65 million, highlighting the alarming scale of the global trade in unapproved and counterfeit medicines.

    Operation Pangea XVII, which took place from December 2024 to May 2025, saw the arrest of 769 suspects and the dismantling of 123 criminal groups worldwide.

    The seizures and arrests are the largest in the operation’s 17-year history.

    Nervous system agents, including psychostimulants, anti-anxiety drugs, and medications for Parkinson’s disease, topped the list as the most seized product type, with erectile dysfunction medicines, the second highest.

    Other commonly seized product types include anabolic steroids, anti-diabetic medicines, anti-smoking products, dermatological agents, health supplements, herbal products and psychotherapeutic agents.

    David Caunter, Director pro tempore of Organized and Emerging Crime at INTERPOL, said:

    “Fake and unapproved medications are a serious risk to public health. They can include dangerous or illegal ingredients potentially resulting in severe illness, or even death.

    “The rapid growth of online platforms has made it easier for these unsafe drugs to reach people as well as opening new opportunities for criminal networks to exploit.

    “Working together through Operation Pangea, countries are taking action to protect people’s health and keep healthcare systems safe.”

    Ethiopian authorities discovered illicit pharmaceuticals hidden inside a container.

    Seizures of anti-diabetic medication in Northern Ireland, United Kingdom.

    Customs inspection at Kuala Lumpur International Airport, Malaysia.

    Inspection at a warehouse in Malaysia.

    Illicit pharmaceuticals seized in Türkiye.

    Illicit pharmaceuticals seized in Malaysia.

     

    Growing demand for anti-diabetic medications and peptide supplements

    The operation revealed growing demand for anti-diabetic drugs and peptide supplements, driven by increasing self-medication, among other factors.

    This trend is being driven by the widespread promotion and availability of these medicines across social media and online marketplaces, creating lucrative and relatively low-risk opportunities for criminal networks selling low-quality or counterfeit products.

    Data from participating countries indicate increasing circulation of illicit anti-diabetic medicines globally due to their off-label weight loss effects, with unapproved and potentially fake drugs seized in the Asia-Pacific, Europe and North America.

    Estimates suggest that a single semaglutide pen may sell for several hundred US dollars on the secondary market.

    The seizures corroborate recent alerts from the World Health Organization and various national health regulatory agencies warning of emerging risks associated with GLP-1-related injectable drugs.

    Operation Pangea XVII revealed another emerging trend – growing demand for peptide supplements for their perceived cosmetic and performance-enhancing benefits, especially in high-income countries across Europe, North America and Oceania.

    These supplements, such as BPC-157, ipamorelin, and melanotan, remain unapproved in many regions due to potential health risks and the lack of sufficient human trials, and until recently, seizures of such peptide-based biologically active substances were rare.

    Ethiopian authorities discovered illicit pharmaceuticals hidden inside a container.

    Illicit pharmaceuticals seized in Argentina.

    Unapproved pregabalin medicines seized in Northern Ireland, United Kingdom.

    Suspected counterfeit tramadol and other medicines seized in Gabon.

    Illicit pharmaceuticals found in a clandestine clinic in Mozambique.

    Illicit erectile dysfunction medicines seized in Bulgaria.

    Operational highlights

    In total, law enforcement agencies worldwide launched 1,728 investigations and issued 847 search warrants targeting criminal networks engaged in the illicit distribution of pharmaceutical products.

    93 per cent of the illicit pharmaceuticals seized lacked regulatory approvals from national health authorities.

    Such products may contain counterfeit, substandard or falsified substances which have not been identified.

    The remaining seven per cent were confirmed as either counterfeit, diverted, or misbranded products.

    Australia recorded the largest seizures globally, with psychostimulants such as modafinil and armodafinil being the most common category seized nationally. This was followed by anti-smoking pouches and erectile dysfunction medicines.

    Professor Tony Lawler, Head of Australia’s Therapeutic Goods Administration (TGA) said:

    “During this operation, the TGA assessed over 9,500 imports referred by the Australian Border Force and facilitated the seizure of over 5.2 million units of unlawfully imported therapeutic goods, including products that were found to be substandard or falsified.

    This operational partnership represents a significant disruption of dangerous medicines from entering our community, and diversion of profits from those that would usually benefit from the illegal sale and supply.”

    Large seizures of various illicit pharmaceuticals were similarly reported in Canada, Ireland, Malaysia, the Netherlands, Portugal, Spain, Sweden, the United Kingdom and the United States, among other countries. 

    Operation Pangea XVII also saw the shutdown of approximately 13,000 criminal-linked websites, social media pages, channels, and bots used to market and sell illegal or falsified medicines.

    Malaysia removed the greatest number of online listings (7,000), followed by Russia, Ireland, Singapore and Iran. The five countries collectively accounted for 96 per cent of all listings taken down.

    In Burkina Faso, 816,000 tablets including analgesics and anti-inflammatories were discovered hidden in vehicles.

    In Mexico, authorities intercepted 27,000 clonazepam tablets and 20,000 alprazolam tablets passing through a courier facility in Tijuana.

    In Portugal, anabolic steroids were discovered in eight prisons across the country, unveiling evidence of a criminal network smuggling illicit substances into correctional facilities.

    Notes to Editor

    Operation Pangea is an annual INTERPOL operation targeting the online sale of illicit pharmaceuticals. The 17th edition of the operation marked a departure from previous iterations with enforcement action taking place over six months instead of the traditional one week. This extended duration allowed for a more comprehensive and sustained effort to disrupt criminal networks.

    Additional support was provided by national health regulatory agencies, Europol, the International Narcotics Control Board, the Pharmaceutical Security Institute, the Transnational Alliance to Combat Illicit Trade, the United Nations Office on Drugs and Crime, the Universal Postal Union, the World Customs Organization and the World Health Organization.

    The following countries participated in Operation Pangea XVII: Argentina, Armenia, Australia, Austria, Azerbaijan, Bahrain, Belarus, Benin, Bolivia, Bosnia and Herzegovina, Botswana, Brazil, Brunei, Bulgaria, Burkina Faso, Cambodia, Cameroon, Canada, Chile, China, Colombia, Comoros, Congo, Costa Rica, Curacao, Cyprus, Czech Rep., Democratic Rep. of Congo, Denmark, Dominican Rep., Ecuador, Ethiopia, Finland, France, Gabon, Georgia, Greece, Guyana, Hong Kong (China), India, Indonesia, Iran, Iraq, Ireland, Jamaica, Kuwait, Laos, Latvia, Lebanon, Madagascar, Malaysia, Maldives, Mexico, Morocco, Mozambique, Myanmar, Netherlands, New Zealand, Northern Ireland (United Kingdom), Niger, Nigeria, Norway, Pakistan, Palestine, Paraguay, Peru, Philippines, Poland, Portugal, Qatar, Rep San Marino, Romania, Russia, Rwanda, Senegal, Serbia, South Africa, Singapore, Slovakia, Spain, Sri Lanka, St Lucia, Sweden, Thailand, Togo, Türkiye, Ukraine, United Kingdom, United States of America, Uruguay, Venezuela and Zimbabwe.

    MIL Security OSI –

  • MIL-OSI: Nerve Calm: Exploring the Science and Safety Behind a Popular Natural NerveCalm Supplement

    Source: GlobeNewswire (MIL-OSI)

    BOCA RATON, FL, June 25, 2025 (GLOBE NEWSWIRE) — In 2025, the conversation around nerve health is changing. Once seen as a niche concern limited to aging adults or those with severe physical injuries, nerve discomfort is now understood as a growing issue with broader implications for stress management, lifestyle health, and aging wellness. Amidst this shift, one product is making quiet but measurable strides: Nerve Calm.

    As its name suggests, Nerve Calm is built around a singular mission—supporting calmer, more resilient nerve function through scientifically informed, natural means. As millions of individuals report experiences with tingling sensations, sharp discomfort in extremities, and general nerve sensitivity, this supplement is emerging as a thoughtful response to a rising need.

    What Is Nerve Calm?

    Nerve Calm is a nutraceutical formula developed to promote neurological wellness, especially in cases involving nerve overactivity, age-related degeneration, or inflammation-linked sensitivity. Unlike conventional nerve medications, which may involve dependency or numb broad nerve pathways, Nerve Calm offers a natural, non-pharmaceutical alternative.

    The formula contains carefully selected bioactive compounds that work together to support calm nerve signaling, ease physical tension, and encourage circulation to nerve-rich tissues—particularly in the hands, feet, lower back, and neck.

    Built for daily use, Nerve Calm targets the root systems of nerve dysfunction, aiming to support the body’s inherent capacity to repair and rebalance itself. This includes modulating inflammation, improving nerve insulation, and providing essential micronutrients for neurological resilience.

    Why Modern Lifestyles May Be Harming Nerve Health

    According to official website, In today’s hyper-connected world, the average adult spends more hours seated, staring at screens, and consuming processed foods than ever before. This shift has quietly taken a toll—not only on cardiovascular health and metabolism but also on the nervous system. Repetitive postures, nutrient-depleted diets, chronic inflammation, and constant digital stimulation are emerging as key contributors to nerve-related discomfort and dysfunction.
    Poor circulation, blood sugar instability, and vitamin deficiencies—especially B-vitamins—can lead to compromised nerve signaling over time. What once seemed like occasional tingling or fatigue may gradually evolve into persistent burning sensations, numbness, or unexplained nerve sensitivity.
    Compounding this challenge is the body’s natural aging process, which slows down cellular repair and heightens vulnerability to oxidative stress. These modern pressures accelerate wear and tear on nerve pathways, even among individuals without a clinical diagnosis.
    This is where Nerve Calm enters the conversation—not as a reactionary treatment, but as a proactive solution. Its formula was developed to address the root causes of modern nerve stress, replenishing nutrients, reducing inflammation, and supporting neurological resilience in the face of daily strain. In short, Nerve Calm responds to a modern problem with a modern, natural answer.

    How Nerve Calm Works

    Nerve Calm works by influencing several critical mechanisms of nerve health:

    1. Reducing Neuroinflammation: Chronic inflammation is one of the top contributors to nerve discomfort. Nerve Calm includes anti-inflammatory compounds such as turmeric extract (standardized to curcumin) and alpha-lipoic acid that may help ease pressure on irritated nerve endings.
    2. Supporting Myelin Regeneration: Healthy nerves are coated in a protective layer called myelin. Deficiencies in B-vitamins—especially B1 (thiamine), B6, and B12—can lead to myelin breakdown. Nerve Calm supplies these nutrients in bioavailable forms to assist with restoration and conduction efficiency.
    3. Enhancing Circulation: Poor blood flow can reduce nutrient delivery to nerve tissues. Nerve Calm includes botanicals that promote microcirculation, helping improve oxygen and nutrient access to peripheral nerves.
    4. Balancing Nervous System Activity: Adaptogens like passionflower and feverfew support stress resilience and help modulate the body’s stress response, which can otherwise intensify nerve signal sensitivity.

    By addressing these areas simultaneously, Nerve Calm creates an environment that promotes long-term nerve comfort, rather than masking symptoms.

    Visit Official Website To get More Information

    Science Behind Its Key Ingredients

    Every ingredient in NerveCalm has been selected based on clinical studies and peer-reviewed research in neurology and integrative medicine. Some of the standout components include:

    • Corydalis yanhusuo: A staple of traditional Chinese medicine, Corydalis has been shown to modulate nerve signaling pathways and help ease mild neuropathic symptoms—a natural, historically grounded option for nerve calming.
    • Marshmallow Root (Althaea officinalis): Rich in soothing mucilage, this botanical forms a gentle barrier around irritated nerve tissues and supports inflammatory response regulation.
    • California Poppy (Eschscholzia californica): Traditionally used as a nerve tonic, studies suggest it aids in relaxation without heavy sedation—helping promote restorative nerve balance.
    • Prickly Pear Extract (Opuntia spp.): A powerful antioxidant that helps neutralize oxidative stress around nerve fibers, protecting against environmental and metabolic wear.
    • Passionflower Extract: Linked to increased GABA and mild nervous-system relaxation, it provides gentle support to overstimulated nerves as part of the fast-acting complex.
    • Magnesium Glycinate: Known for its bioavailable, gut-friendly form, magnesium aids healthy nerve conduction and muscular relaxation—crucial for overall nerve comfort. 

    By combining these ingredients, NerveCalm delivers a multi-phase, science-backed strategy: it soothes, shields, and supports nerves—promoting gradual restoration and lasting calm without relying on pharmaceuticals.

    Who Created Nerve Calm?

    As per official website getnervecalm.com, The development of NerveCalm was guided by a multidisciplinary team of specialists in nutritional neuroscience, integrative health, and herbal pharmacology. According to the brand’s internal sources, the formula emerged from a two-year development process that analyzed over 300 studies on nerve function, neuroinflammation, and supplement-based nerve recovery.

    Nerve Calm’s parent company operates under a wellness philosophy rooted in three principles:

    • Clinical integrity: Only evidence-supported ingredients make the final formulation.
    • Clean formulation: Free from synthetic fillers, stimulants, and common allergens.
    • Accessibility: Designed to be easy to use, even for aging populations with limited mobility or complex medication schedules.

    The team’s collective mission was simple but impactful: to offer an over-the-counter solution that aligns with the body’s natural systems, without side effects that could interfere with daily life.

    How to Use It Safely

    Nerve Calm is formulated for once- or twice-daily use, depending on the individual’s need and physician recommendations. The capsules are:

    • Easy to swallow
    • Free of stimulants and sedatives
    • Safe to take with or without food

    The company advises users to take Nerve Calm consistently for 30 to 90 days to experience the full spectrum of its benefits. This timeframe allows for cumulative absorption of the nutrients and herbs, supporting gradual but stable improvement.

    Individuals already using prescription medications for nerve discomfort should consult their healthcare provider to ensure there are no interactions. However, because Nerve Calm is stimulant-free and based on nutrients with GRAS (Generally Recognized As Safe) status, it integrates easily with most wellness plans.

    Visit Official Website To get More Information

    Expert Insights on Nerve Support

    Medical and naturopathic experts have long emphasized the importance of nerve maintenance—particularly after age 40, when cellular renewal begins to slow. According to Dr. Karen Meyer, a nutritional neurologist and board-certified integrative practitioner:

    “Many of my patients with nerve discomfort are surprised to learn how nutrient deficiencies, unmanaged stress, and even blood sugar imbalance can affect nerve signaling. Supplements like Nerve Calm, which combine anti-inflammatory agents with B-complex vitamins, offer an approach that supports both short-term relief and long-term nerve wellness.”

    Her perspective reflects a broader shift in clinical practice—one where natural, preventive interventions are being used alongside (or in place of) pharmaceutical approaches, especially for milder to moderate cases.

    Real-World Applications for Adults 40+

    Adults over the age of 40 make up the majority of Nerve Calm’s user base—and for good reason. This is the demographic most commonly affected by nerve-related issues such as:

    • Peripheral tingling in hands and feet
    • Postural nerve compression from sedentary work
    • Age-related nerve degeneration
    • Lingering nerve sensitivity after injury or surgery

    Many users have also reported benefits related to mobility, grip strength, and improved comfort during nighttime rest—times when nerve discomfort is often at its peak. For those in physically demanding professions, such as tradespeople or nurses, Nerve Calm also offers ongoing maintenance support after long hours of movement and strain.

    Safety, Manufacturing, and Quality Control

    As per official website getnervecalm.com, From a safety standpoint, Nerve Calm is formulated under strict manufacturing protocols. Each capsule is produced in an FDA-registered, GMP-certified facility in the United States, ensuring consistency and regulatory compliance.

    Key safety measures include:

    • Third-party lab testing for purity and potency
    • Non-GMO, gluten-free, and vegan-friendly sourcing
    • No artificial preservatives or chemical binders

    Moreover, the product is shelf-stable for 18–24 months and comes in recyclable packaging with clear usage instructions, making it both eco-conscious and user-friendly.

    The absence of known allergens, soy, or dairy makes Nerve Calm widely suitable for most dietary restrictions, while its lack of sedating ingredients ensures it won’t interfere with work, driving, or cognitive clarity.

    Where to Buy Nerve Calm in 2025

    As of mid-2025, Nerve Calm is available exclusively through the official website. This direct-to-consumer model was adopted to maintain pricing integrity and reduce the risk of counterfeit products—a growing concern in the supplement space.

    Each order is backed by a satisfaction guarantee and ships in discreet packaging. Bulk orders, monthly subscriptions, and single-bottle purchases are all supported, with discounts for first-time users and bundled options for long-term plans.

    The company recommends avoiding third-party marketplaces to ensure authenticity and ingredient quality. Counterfeit or expired products sold on unauthorized sites may not match clinical safety standards or batch test requirements.

    Nerve Calm and Sleep: Supporting Restorative Regeneration

    Nighttime is when the nervous system repairs and resets. Yet, for many experiencing nerve discomfort, sleep is when symptoms peak—resulting in restless legs, tingling hands, or jolts of pain that disrupt deep rest.
    Nerve Calm’s botanical adaptogens and anti-inflammatory nutrients may help calm nighttime nerve agitation, promoting better-quality sleep without drowsiness or medication hangovers.
    Its support for blood flow and oxygen delivery also complements the body’s natural nocturnal repair cycles, making it a wellness ally for those seeking regenerative rest.

    Closing Thought: A Quiet Evolution in Nerve Support

    Nerve Calm’s rise isn’t marked by celebrity endorsements or aggressive advertising. Instead, its strength lies in the quiet endorsement of those who use it—older adults reclaiming restful nights, professionals easing daily discomfort, and wellness practitioners recommending it as a safe alternative to aggressive interventions.

    As the landscape of neurological self-care continues to evolve, the success of Nerve Calm speaks to a broader cultural and scientific movement. One that values precision nutrition, natural support, and respectful integration with the body’s own healing capabilities.

    In a world where overstimulation and chronic stress affect nearly every system, Nerve Calm offers something rare: a supplement that works in harmony with the nervous system rather than against it.

    For more information, educational content, and direct purchasing, visit the official Nerve Calm website.

    Contact: NerveCalm

    4700 NW BOCA RATON BLVD 202 – BOCA RATON FL 33431

    Phone: 1-302-496-4906

    International Order Phone Support: +44 1704 320405

    Order Support – support@beneonature.com

    Website – https://getnervecalm.com/

    Legal Disclaimer

    The information provided in this article is for informational and educational purposes only and should not be construed as medical advice. It does not replace the advice of a qualified healthcare professional. Readers should not use this information to diagnose or treat any health problem or condition. Individuals should always consult their healthcare provider before starting any new supplement, medication, or health program.

    While the content in this article has been carefully researched and reviewed, no guarantee is given regarding the accuracy, completeness, or reliability of the information presented. Any reliance placed on such information is strictly at the reader’s own risk. The publisher, authors, and syndication partners assume no responsibility or liability for any errors, omissions, or inaccuracies in the content or for any consequences arising from its use.

    The product discussed in this article, NerveCalm, is a dietary supplement intended to support overall wellness. It is not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary. Statements regarding dietary supplements have not been evaluated by the Food and Drug Administration.

    This article may contain views and opinions which do not necessarily reflect those of the publisher or its affiliates. All products or services referred to are presented without any warranty of any kind, either express or implied.

    Attachment

    The MIL Network –

  • MIL-OSI: Coolizi Cooling Ace: Why Coolizi Emerges as a Leading Cooling Tech AC in 2025

    Source: GlobeNewswire (MIL-OSI)

    Atlantic City, NJ, June 25, 2025 (GLOBE NEWSWIRE) — As rising global temperatures redefine daily life, a new class of personal cooling solutions is stepping into the spotlight. One product at the forefront is Coolizi Cooling Ace—a compact, bladeless, wearable cooling device designed to provide rapid and targeted relief in high-heat environments. In 2025, Coolizi is not just keeping users cool—it’s transforming how individuals manage comfort, health, and productivity during warmer months.

    A Timely Innovation: Addressing Rising Temperatures with Wearable Cooling

    From heatwaves to humid indoor spaces, consumers are increasingly seeking smarter ways to stay cool without relying on bulky, energy-draining appliances. Coolizi Cooling Ace enters the market at a critical time, offering a portable, personal cooling solution powered by advanced airflow and thermoelectric compression technology.

    With growing awareness of heat-related fatigue and wellness impacts, Coolizi is being positioned as more than a gadget—it’s a daily-use health and comfort enhancer for modern living.

    Inside the Coolizi Cooling Ace: Compact Design, Big Impact

    In the ever-evolving landscape of personal wellness technology, Coolizi Cooling Ace emerges as a standout innovation—thanks to its thoughtfully engineered, compact design. Shaped to fit comfortably around the neck, the device delivers discreet, targeted cooling to critical temperature-sensitive zones, making it an ideal solution for hot commutes, outdoor tasks, and indoor settings lacking adequate ventilation. Its form factor is feather-light, eliminating the strain often associated with neck-mounted accessories, while the airflow outlets are strategically positioned to maximize cooling efficiency without obstructing movement or conversation.
    The impact of this compact design extends beyond comfort. The wearable nature of the Coolizi Cooling Ace allows for hands-free operation, eliminating the need for handheld fans or stationary coolers. It’s engineered with lifestyle adaptability in mind—equally effective whether one is walking, working, or winding down. With a sleek, minimal aesthetic and a universally adjustable fit, it seamlessly integrates into any routine, regardless of age or occupation. In a market flooded with bulky gadgets, Coolizi’s ability to deliver precise thermal relief in a streamlined form marks it as a category-defining product. For users looking to stay cool without compromise, Coolizi is rapidly becoming the go-to wearable cooling solution of 2025.
    Visit Official Website To get More Information

    Engineering Breakthrough: How German Turbo Compression Powers Coolizi

    At the core of the Coolizi Cooling Ace is a technological advancement that separates it from standard personal cooling devices: German-engineered Turbo Compression technology. Unlike traditional fans that simply recycle warm air, this innovation actively cools the air drawn in before distributing it to the body. Through an advanced thermoelectric process, ambient air is compressed and rapidly cooled using a proprietary system, then released through bladeless, skin-safe outlets positioned along the collar frame.
    This breakthrough not only delivers a faster cooling response—it ensures sustained temperature reduction over long usage periods. The science behind Turbo Compression eliminates reliance on water tanks, ice packs, or refrigerants, making Coolizi a low-maintenance, eco-conscious cooling tool that still achieves superior results. Early users report a noticeable drop in perceived body temperature within just 30 seconds of activation, particularly in high-heat environments where traditional fans fall short.
    Furthermore, the system is whisper-quiet, registering at just ~20 decibels, ensuring that relief comes without disruptive noise. Whether used during sleep, study, or work, this engineering leap provides comfort without compromise. In the age of wearable wellness devices, Coolizi stands at the forefront, turning climate resilience into an effortless, daily reality.

    Three Cooling Modes, One Goal—Immediate Personal Relief

    As per official website, Users can toggle between the three preset modes to match their environment:

    • Cool: For mild relief during spring or indoor use.
    • Chill: For moderate summer days or post-workout cool-down.
    • Freeze: For extreme heat, including outdoor work or heatwaves.

    All modes operate at just ~20dB, making the device suitable for use during calls, sleep, or focused tasks—an uncommon feature among portable cooling units.

    Whisper-Quiet Operation: Designed for Work, Rest, and Recovery

    Noise-sensitive users—such as remote workers, students, and light sleepers—are responding positively to Coolizi’s low-decibel performance. Testimonials highlight the device’s ability to operate silently while providing real airflow and temperature reduction.

    This makes Coolizi a viable option not only for recreational use but also in workplace, wellness, and therapeutic settings where quiet environments are essential.

    Built for the Modern User: Portable, Rechargeable, and Maintenance-Free

    According to official website coolizi.com, Today’s consumers demand solutions that are not only effective but also effortlessly integrated into daily life. The Coolizi Cooling Ace is a prime example of how design and function converge to meet that need. Built for the fast-paced, tech-enabled lifestyles of 2025, this cooling device is entirely cordless, USB-C rechargeable, and free from the frequent upkeep typical of traditional air units. With a full charge, users can expect up to 8 hours of continuous cooling, making it perfect for workdays, travel, or extended outdoor use.
    The device’s portability is one of its most valued features. Whether tossed in a bag or worn in transit, Coolizi requires no installation, refilling, or cleaning, making it ideal for those who seek simplicity and efficiency. Its streamlined charging method—compatible with standard USB-C ports—means it pairs seamlessly with existing tech setups, from laptops to car adapters.
    Perhaps most notably, Coolizi is designed with durability and zero-maintenance operation in mind. Without fans, filters, or fragile blades, there’s little risk of mechanical failure. For users who want climate relief without additional chores, Coolizi provides a modern solution that respects time, energy, and convenience—hallmarks of next-generation wellness design.

    Cooling Where It Matters: From Commutes to Campsites

    From city commuters and construction crews to beachgoers and hikers, Coolizi’s versatile design supports a wide range of use cases. Its impact is especially notable in regions where temperatures often soar above 90°F and traditional AC units offer limited relief.

    The device is also gaining traction among travelers, RV users, and senior citizens looking for personal cooling without environmental noise or installation hassle.

    Healthcare Meets Climate Tech: Supporting Well-Being in High Heat

    As awareness grows around heat-induced fatigue, dehydration, and focus disruption, Coolizi is being integrated into daily health routines. Many users adopt it as a preventative tool against heat stress, particularly those with underlying health conditions, or those living in regions with poor air circulation or high humidity.

    This intersection of climate-responsive design and personal wellness support is part of what drives Coolizi’s AC growing reputation.

    What Users Are Saying: Real Experiences with Coolizi Cooling Ace

    With over 7,800 verified users and an average rating of 5.0/5.0, the Coolizi Cooling Ace is resonating strongly with consumers. Verified purchasers report “instant cooling,” “ultra-quiet airflow,” and describe it as “a lifesaver for daily commutes.”

    One user writes:

    “I was skeptical at first, but Coolizi worked straight out of the box. It’s now a daily must-have on my walk to work.”

    Visit Official Website To get More Information

    Why Coolizi Is Gaining Ground in the U.S. Markets

    As climate conditions intensify and the demand for smarter cooling solutions rises, Coolizi Cooling Ace is capturing attention not only across the United States but also in several international markets. In 2025, this wearable cooling innovation has swiftly transitioned from niche product to mainstream necessity—particularly among urban dwellers, outdoor professionals, and wellness-conscious consumers. What sets Coolizi apart in the global market is its ability to merge technology, comfort, and accessibility into a single, portable solution. In the U.S., rising temperatures have spurred a wave of interest in personal climate tech, with users seeking alternatives to energy-intensive air conditioners. Coolizi’s energy-efficient performance, paired with its maintenance-free design and silent operation, has made it a strong contender for both individual and workplace use. 
    Internationally, markets such as Australia, Canada, and parts of Europe have echoed similar praise. The device’s universal USB-C charging, lightweight build, and multi-mode functionality allow it to easily adapt to diverse climates and lifestyles. With no complicated setup or regional power limitations, Coolizi’s plug-and-go usability makes it ideal for global distribution. As momentum builds through positive user reviews and repeat purchases, Coolizi Cooling Ace is rapidly evolving into a household name in wearable comfort technology.

    Expert Insights: What Makes Coolizi Different from Traditional Mini Coolers

    Industry experts agree: while many portable coolers promise comfort, Coolizi Cooling Ace delivers it with a combination of scientific precision, portability, and long-term usability. Unlike mini air conditioners or desktop fans that rely on water tanks, external plugs, or refrigerants, Coolizi uses solid-state thermoelectric cooling paired with Turbo Compression technology. This not only reduces operating noise and maintenance—it increases real-time performance where it matters most: directly on the body.
    Another defining advantage is Coolizi’s bladeless safety design, which ensures quiet operation and makes it suitable for all age groups—including children and seniors. Experts note that many users overlook the risk of injury or discomfort with fan-based systems. Coolizi avoids this altogether while achieving cooler output in a fraction of the time.
    Its ergonomic neckband style is also seen as a functional evolution of traditional cooling formats. Experts emphasize that wearable tech should be intuitive and lifestyle-friendly, and Coolizi checks both boxes. It doesn’t just sit on a desk or require setup—it moves with the user, offering true mobility and freedom.
    As consumer expectations evolve, Coolizi has been identified by product analysts as a category leader, bridging the gap between comfort tech and wearable wellness—a distinction few brands can claim.

    Buyer Awareness: Official Site Access and Stock Availability

    To ensure product authenticity and avoid imitation units, Coolizi is currently only sold through its official website. The manufacturer does not authorize sales on third-party platforms or local retail stores.

    Users can order directly with secure checkout, email confirmation, and tracking support—providing peace of mind from order to delivery.

    A Look Ahead: How Coolizi Is Shaping the Future of Personal Cooling

    In a world where comfort technology is becoming increasingly personal and mobile, Coolizi Cooling Ace stands out for its smart engineering, ease of use, and measurable benefits. As 2025 unfolds, this compact cooling solution is expected to remain a leading force in wearable tech and thermal wellness.

    For more information, visit the official Coolizi Cooling Ace website and explore limited-time summer offers while supplies last.

    Company: Coolizi Cooling ACE
    SB Brands 78 John Miller Way Kearny,
    New Jersey 07032
    Email: Support@chillreleaf.com
    Website: https://www.coolizi.com

    Disclaimers and Disclosures 

    The information presented in this article is strictly for general informational and educational purposes. It does not, in any way, constitute professional advice, diagnosis, or treatment of any medical or health condition. Please note that Coolizi Cooling ACE is not a medical device and is not intended to prevent, treat, or cure any health condition. Any references to comfort or relief are purely anecdotal and should not be interpreted as medical claims. 

    It is strongly recommended that readers consult a licensed medical professional or HVAC specialist before considering any cooling product for medical or health-related use. Please be aware that individual results may vary depending on environmental conditions, usage patterns, and personal sensitivity to temperature or humidity changes. Product specifications, features, and pricing referenced in this content are accurate at the time of publication to the best of the author’s knowledge. However, they are subject to change at the discretion of the manufacturer or vendor without prior notice. 

    Consumers should always refer to the official Coolizi Cooling ACE website for the most current information regarding pricing, warranties, and product availability. It’s important to note that this article may include affiliate links. However, these relationships do not influence the editorial content, which remains independent and impartial. The publisher may earn a commission if a purchase is made through these links, but this comes at no additional cost to the consumer. While every effort has been made to ensure the accuracy and up-to-date nature of the information presented here, it’s important to note that neither the author nor any distribution partners assume responsibility for typographical errors, omissions, or outdated product details that may appear in the article. The publisher and its syndication partners expressly disclaim any liability for actions taken by readers based on the content provided herein. Lastly, it’s important to reiterate that all product names, trademarks, and registered trademarks used in this article are the property of their respective owners. Their use here does not imply any affiliation with or endorsement by these entities. Please remember, the information provided here is not medical advice, and it’s crucial to consult a professional before making any health-related decisions.

    Attachment

    The MIL Network –

  • MIL-OSI United Kingdom: Local Area Inclusion Plan: Supporting Derby’s young people to live their best life

    Source: City of Derby

    Inclusion is at the heart of our work at the council, and this week we’ve published our new Local Area Inclusion Plan, setting out clearly how we’re tackling important issues such as health, community, and job opportunities for Derby’s children and young people, particularly for those who with Special Educational Needs and Disabilities (SEND) and those in Alternative Provision (AP). 

    Following consultation with over 2,000 Derby stakeholders, including schools, children and young people, parent/carers and families, we’ve set out three core aims, underpinned with objectives and practical plans to make sure that children and young people ages 0-25 are supported to achieve strong outcomes and positive destinations. 

    The three interconnected aims are:

    • Aim 1 – Champion an ambitious and inclusive city
    • Aim 2 – Meet the needs of our children at the right time and place
    • Aim 3 – A strong, collaborative system that helps our children live their best life.

    Councillor Paul Hezelgrave, Derby City Council Cabinet Member for Children, Young People and Skills, describes the importance of this collaborative approach to strategy:

    Our children and young people deserve the very best from those who are making decisions on their behalf. Through co-production with these youngsters, this plan sets out how we effectively prepare them for the future and get them closer to the labour market, developing clear pathways with support from businesses.

    This ensures that Derby’s young people feel supported, empowered and included, and that their voice has been heard and acted upon.

    At its core, the Local Area Inclusion Plan promotes inclusion across the community and in mainstream settings, finding ways to support young people earlier and reducing the pressures on specialist services. In consultation with young people, the plan sets out six key outcomes that Derby’s young people have stated are vital to living their best life.

    These are:

    • I have real-life experiences, learning opportunities, good careers advice and guidance, and insight into the world of work
    • I have a plan for my future
    • I am active, independent and take part in my local community
    • I enjoy good physical and mental health and live a healthy lifestyle 
    • I am supported to dream big
    • Those that care for me understand how they can help me and realise my potential.

    Andy Smith CBE, Strategic Director of People Services, explains:

    Every child in Derby deserves to be seen, heard, and supported to thrive. This plan is our commitment—to work together across services so children, young people, and their families get the right help at the right time, for the brightest futures possible.

    Sharon Buckby, Director of Learning, Inclusion and Skills, is confident that this plan will lead to better outcomes for Derby’s children and young people. She said:

    Our holistic approach to inclusion means that we are supporting children and young people at the right time, in the right place with a focus on early intervention.

    We do also understand that there is a need for specialist intervention in some cases, and this plan looks to address some of those challenges with long waits for assessment.  We are passionate about supporting every young person to achieve their potential.

    Jo Hunter, Deputy Chief Nurse, highlighted the collaborative nature of the work:

    Collaborative working across the local area, knowledge exchange and an understanding of experiences of the system has really strengthened our approach to inclusion.

    Taking a multi-disciplinary approach to areas of need means our response can be strengths based, insightful and targeted, leading to the effective use of resources and best possible outcomes for young people with physical disabilities and special educational needs.

    The Local Area Inclusion Plan is available to read on our website, in an easily digestible, at-a-glance format.

    MIL OSI United Kingdom –

  • MIL-OSI United Kingdom: MHRA seizes 7.7 million doses of illegal medicines and removes hundreds of illegal online listings as part of Operation Pangea

    Source: United Kingdom – Government Statements

    Press release

    MHRA seizes 7.7 million doses of illegal medicines and removes hundreds of illegal online listings as part of Operation Pangea

    Operation Pangea brings together health regulators, customs authorities, law enforcement agencies, and private sector partners to tackle the threat posed by global criminal networks

    The Medicines and Healthcare products Regulatory Agency (MHRA) has seized almost eight million doses of illegal medicines as part of an annual global coordinated operation to tackle the illegal online sale of medicines and medical devices.

    Operation Pangea, coordinated by Interpol and involving around 90 countries, is the world’s largest initiative of its kind. It brings together health regulators, customs authorities, law enforcement agencies, and private sector partners to tackle the threat posed by criminal networks operating in the global supply of illegal medicines.

    This year’s operation took place between December 2024 and May 2025. Working with law enforcement partners, the MHRA’s Criminal Enforcement Unit (CEU) seized 7.7 million doses of illicit medicines with an estimated value of £17.2m. Among the products seized in the UK were various prescription-only medications including powerful painkillers, anti-depressants and sleeping pills.

    The CEU also coordinated several arrest operations, denied gangs access to almost £1.4m in criminal profits, and removed 367 websites and social media accounts offering medical products to the public illegally.

    Do not self-prescribe.

    Self-diagnosis and self-medication can be very dangerous. If you have a concern about your health, seek advice from a healthcare professional and only obtain medicines from a trusted source.

    Visit the #FakeMeds website for tools and resources to help people purchase medication or medical devices safely online.

    Andy Morling, who heads the MHRA’s Criminal Enforcement Unit (CEU), said:

    Criminals trade in illegal medicines for no other reason than to make money. Not only are these people breaking the law, but they also have no regard for your health.

    Buying medicines from unverified sources, online or elsewhere, means there is no guarantee that the products are safe or effective. Some can contain dangerous or illegal ingredients that could result in severe illness, addiction or even death.

    People also need to be aware that turning to illegal online sellers can leave them exposed to bank fraud and identity theft.

    This year’s operation is another example of how the MHRA and its international partners are joining forces to tackle the criminal gangs causing so much misery and harm around the world.

    Notes to editors

    • Anyone who suspects they are having a side effect from a medicine are encouraged to talk to their doctor, pharmacist or nurse and report it directly to the MHRA Yellow Card scheme, either through the Yellow Card website or by searching the Google Play or Apple App stores for MHRA Yellow Card.
    • The MHRA’s Accredited Financial Investigators are authorised by the National Crime Agency under the Proceeds of Crime Act 2002 (POCA). They support investigations by tracing, freezing, and confiscating assets linked to crime, including money laundering and the illegal supply of medicines. Their work includes seizing cash, valuable items, and freezing bank accounts or cryptocurrency suspected of criminal origins. The Home Office’s Asset Recovery Incentivisation Scheme (ARIS) allows a proportion of the proceeds of crime recovered under POCA, to be redistributed to agencies involved in the asset recovery process. The Home Office encourages agencies to invest ARIS funds to drive up performance on asset recovery or, where appropriate, to fund local crime fighting priorities for the benefit of the community.
    • Operation Pangea is a global initiative coordinated by INTERPOL that targets the illegal online sale and distribution of unlicensed and counterfeit medicines and medical devices. Involving police, customs, health regulators, and private sector partners across approximately 90, the operation aims to protect public health by disrupting criminal networks and raising awareness of the dangers of buying medicines from unregulated sources.
    • The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for regulating all medicines and medical devices in the UK by ensuring they work and are acceptably safe.  All our work is underpinned by robust and fact-based judgements to ensure that the benefits justify any risks. 
    • The MHRA is an executive agency of the Department of Health and Social Care. 
    • For media enquiries, please contact the newscentre@mhra.gov.uk, or call on 020 3080 7651.

    Updates to this page

    Published 25 June 2025

    MIL OSI United Kingdom –

  • MIL-OSI Canada: Canada renews support to protect the world’s children against infectious diseases

    Source: Government of Canada News (2)

    June 25, 2025 – Ottawa, Ontario – Global Affairs Canada

    Vaccines are one of the world’s most effective, evidence-based health interventions. This is true no matter where in the world a child lives. Each year, Gavi, the Vaccine Alliance, provides immunizations for more than half the children born into the world, saving millions of them from life-threatening diseases like human papillomavirus (HPV), malaria, measles and polio.

    Today, the Honourable Randeep Sarai, Secretary of State (International Development), concluded his participation in Gavi’s pledging conference held in Brussels, Belgium, on June 25, 2025.

    At the conference, Secretary Sarai reiterated Canada’s renewed commitment to global immunization efforts through its previously announced pledge of $675 million over the next five years (2026-2030), for Gavi, The Vaccine Alliance.

    Gavi’s work has significant implications for global economic growth and health security and is projected to create more than $100 billion in economic benefits for supported countries over the next 5 years. Canada’s support will help Gavi provide life-saving vaccines to at least 500 million more children, preventing over 8 million deaths, protecting the world against future pandemics and disease outbreaks, as well as strengthening health systems and global health security. It will also support exciting innovations, including the rollout of the groundbreaking new malaria vaccine, as well as practical, climate-smart solutions, such as installing more than 20,000 solar-powered fridges and freezers to ensure life-saving doses stay cold in remote areas.

    On the sidelines of the conference, Secretary Sarai met with key leaders in global health, including representatives from implementing countries and heads of major organizations. These included Dr. Tedros Adhanom Ghebreyesus, Director-General of the WHO, Catherine Russell, UNICEF’s Executive Director, Dr. Mekdes Daba, Ethiopia’s Minister of Health, Dr. Muhammad Ali Pate, Nigeria’s Minister of Health, and Bill Gates. They discussed the future of global health efforts and the importance of sustained collaboration and innovation, to protect the progress made so far. Secretary Sarai also reaffirmed Canada’s steadfast commitment to Gavi and to making vaccines more accessible as the cornerstone of global health security.

    MIL OSI Canada News –

  • MIL-OSI USA: Attorney General James Affirms Hospitals Must Provide Access to Emergency Abortion Care

    Source: US State of New York

    EW YORK – New York Attorney General Letitia James co-led 21 other attorneys general in a letter reminding hospitals of their obligation to provide emergency abortion care under the Emergency Medical Treatment and Active Labor Act (EMTALA). In a letter sent to the American Hospital Association on the third anniversary of the Supreme Court’s decision overturning Roe v. Wade, Attorney General James and the coalition advised hospitals that their obligation to comply with EMTALA’s emergency abortion care requirement has not changed despite the federal administration’s recent decision to revoke a prior guidance document.

    “When a pregnant patient shows up at an emergency room in need of help, they should never be turned away,” said Attorney General James. “Our hospitals have a legal responsibility to ensure they are providing life-saving care to all patients in need – including emergency abortion care when necessary. It is critically important that providers be aware of this obligation, so that we avoid further tragedy and save as many lives as possible.”

    Since it was enacted in 1986, EMTALA has required Medicare-participating hospitals to provide access to abortion care when it is the treatment necessary to stabilize a pregnant patient with an emergency medical condition. On May 29, 2025, the Centers for Medicare and Medicaid Services (CMS) rescinded guidance that had been issued in 2022 in the wake of the Supreme Court’s decision overturning Roe v. Wade. The 2022 guidance addressed EMTALA’s requirements to provide access to emergency abortion care, but it also did not change EMTALA’s statutory mandates.

    In the letter, Attorney General James and the coalition explain that the administration’s rescission of the 2022 guidance in no way alters hospitals’ legal obligations under EMTALA. The attorneys general highlight that EMTALA has always required hospitals to provide access to abortion care if it is the treatment necessary to stabilize pregnant patients with an emergency medical condition, even if the state in which they operate has passed laws limiting abortion access. Emergency medical conditions that require stabilizing abortion treatment can include, but are not limited to, ectopic pregnancy, hemorrhaging, preeclampsia, and other significant life-threatening conditions.

    The attorneys general assert that the Trump administration cannot change the law unilaterally through a guidance rescission, and EMTALA continues to remain in full force and effect throughout the country. The attorneys general also explain that continued compliance with EMTALA’s requirements is critical because of the devastating harms that result from denying abortion care to pregnant patients in emergency medical situations. The letter points out that the denial of this essential care increases the risk of death for pregnant patients and can cause irreparable harm, including hysterectomy, fertility loss, kidney failure, brain injury, and limb amputation.

    With this letter, Attorney General James and the coalition are reaffirming their commitment to ensuring that hospitals comply with the law and their commitment to protecting pregnant patients across the country.

    Joining Attorney General James in sending this letter are the attorneys general of Arizona, California, Colorado, Connecticut, Delaware, Hawaii, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, Nevada, New Jersey, New Mexico, North Carolina, Oregon, Rhode Island, Vermont, Washington, and the District of Columbia.

    MIL OSI USA News –

  • MIL-OSI: ESO’s Auto-Generated Narrative Feature Returns 35,700 Hours to EMS Professionals in First Month

    Source: GlobeNewswire (MIL-OSI)

    AUSTIN, Texas, June 25, 2025 (GLOBE NEWSWIRE) — ESO, a leading data services and software provider for EMS, fire departments, hospitals, and government agencies, today announced significant adoption and time-savings as a result of its new Auto-Generated Narrative feature. Launched in May 2025, the AI-powered documentation saved over 35,700 hours for EMS professionals within its first month of general availability. Over 1,670 EMS agencies have adopted the feature since May—resulting in up to 80% reduction in total documentation time.

    ESO’s first generation Auto-Generated Narrative feature, included for existing Electronic Health Record (EHR) customers, transforms the traditionally time-consuming patient care report process by generating comprehensive narrative summaries from data captured in patient records from various sources, including speech to text, while maintaining the highest standards of data security and patient privacy. Additionally, ESO’s EHR longitudinal record feature connects patient records across an individual’s medical history and hospital visits, importing medications, allergies and demographics from previous healthcare encounters.

    “Our approach to AI is fundamentally about empowerment,” said John Basmadjian, chief product and technology officer at ESO. “We developed our Auto-Generated Narrative with patients and providers in mind, ensuring it enables the expertise of EMS professionals while maintaining the highest standards of clinical accuracy and professional responsibility. This technology addresses real-world challenges our customers face daily—giving them more time for patient care while ensuring complete, consistent documentation.”

    The feature maintains NEMSIS compliance and includes built-in safeguards that require provider review and approval before finalizing any narrative. Healthcare professionals retain complete control throughout the process, with the ability to edit, augment, modify or regenerate content as needed. The feature is intentionally designed to be entirely optional, giving EMS organizations the option to implement this capability based on their preferences and internal policies.

    “The amount of time our team spends on documentation and reporting has decreased significantly—with crews now reducing their documentation time by 20 minutes per report,” said Jeff Sadtler, chief at West County Fire and EMS. “But what’s most important is that our field crews maintain complete control and responsibility over their documentation. They’re not just accepting what the AI generates, they’re using it as a foundation to supplement, creating accurate, comprehensive reports that truly reflect the care delivered to our patients.”

    The Auto-Generated Narrative feature represents ESO’s continued commitment to innovation with purpose. It accompanies other recent enhancements to ESO’s EHR platform, such as longitudinal record keeping, which enables EMS agencies to access vital patient data before, during and after care for a more holistic view of the patient’s long-term health.

    ESO’s Auto-Generated Narrative feature is now accessible across its EHR platforms, including native iOS, Windows mobile and web applications, and can be activated organization-wide through administrative settings. For more information on ESO, visit www.eso.com.

    About ESO
    ESO is dedicated to improving community health and safety through the power of data. Since its founding in 2004, the company continues to pioneer innovative, user-friendly software to meet the changing needs of today’s global emergency response ecosystem, spanning across dispatch centers, EMS agencies, fire departments, hospitals, and governmental offices. ESO currently serves thousands of customers across the globe with a broad software portfolio, including the industry-leading ESO Electronic Health Record (EHR), the next generation ePCR; ESO Health Data Exchange (HDE), the first-of-its-kind healthcare interoperability platform; ESO Fire RMS, the modern fire Record Management System; Logis by ESO Dispatch and Billing solutions; ESO Patient Registry (trauma, burn and stroke registry software); and ESO State Repository. For more information, visit www.eso.com.

    Media Contact:
    For ESO,
    Hope Sander
    Red Fan Communications
    eso@redfancommunications.com
    737-280-8783

    The MIL Network –

  • MIL-OSI United Kingdom: Local Area Inclusion Plan: How we’re tackling important issues for Derby’s children

    Source: City of Derby

    Inclusion is at the heart of our work at the council, and this week we’ve published our new Local Area Inclusion Plan, setting out clearly how we’re tackling important issues such as health, community, and job opportunities for Derby’s children and young people, particularly for those who with Special Educational Needs and Disabilities (SEND) and those in Alternative Provision (AP). 

    Following consultation with over 2,000 Derby stakeholders, including schools, children and young people, parent/carers and families, we’ve set out three core aims, underpinned with objectives and practical plans to make sure that children and young people ages 0-25 are supported to achieve strong outcomes and positive destinations. 

    The three interconnected aims are:

    • Aim 1 – Champion an ambitious and inclusive city
    • Aim 2 – Meet the needs of our children at the right time and place
    • Aim 3 – A strong, collaborative system that helps our children live their best life.

    Councillor Paul Hezelgrave, Derby City Council Cabinet Member for Children, Young People and Skills, describes the importance of this collaborative approach to strategy:

    Our children and young people deserve the very best from those who are making decisions on their behalf. Through co-production with these youngsters, this plan sets out how we effectively prepare them for the future and get them closer to the labour market, developing clear pathways with support from businesses.

    This ensures that Derby’s young people feel supported, empowered and included, and that their voice has been heard and acted upon.

    At its core, the Local Area Inclusion Plan promotes inclusion across the community and in mainstream settings, finding ways to support young people earlier and reducing the pressures on specialist services. In consultation with young people, the plan sets out six key outcomes that Derby’s young people have stated are vital to living their best life.

    These are:

    • I have real-life experiences, learning opportunities, good careers advice and guidance, and insight into the world of work
    • I have a plan for my future
    • I am active, independent and take part in my local community
    • I enjoy good physical and mental health and live a healthy lifestyle 
    • I am supported to dream big
    • Those that care for me understand how they can help me and realise my potential.

    Andy Smith CBE, Strategic Director of People Services, explains:

    Every child in Derby deserves to be seen, heard, and supported to thrive. This plan is our commitment—to work together across services so children, young people, and their families get the right help at the right time, for the brightest futures possible.

    Sharon Buckby, Director of Learning, Inclusion and Skills, is confident that this plan will lead to better outcomes for Derby’s children and young people. She said:

    Our holistic approach to inclusion means that we are supporting children and young people at the right time, in the right place with a focus on early intervention.

    We do also understand that there is a need for specialist intervention in some cases, and this plan looks to address some of those challenges with long waits for assessment.  We are passionate about supporting every young person to achieve their potential.

    Jo Hunter, Deputy Chief Nurse, highlighted the collaborative nature of the work:

    Collaborative working across the local area, knowledge exchange and an understanding of experiences of the system has really strengthened our approach to inclusion.

    Taking a multi-disciplinary approach to areas of need means our response can be strengths based, insightful and targeted, leading to the effective use of resources and best possible outcomes for young people with physical disabilities and special educational needs.

    The Local Area Inclusion Plan is available to read on our website, in an easily digestible, at-a-glance format.

    MIL OSI United Kingdom –